<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "http://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1" specific-use="sps-1.9" xml:lang="pt">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id specific-use="scielo-v3" pub-id-type="publisher-id">brYTWzmgjZhpx6Bn3xGxWPP</article-id>
      <article-id specific-use="scielo-v2" pub-id-type="publisher-id">S0066-782X2024000500310</article-id>
      <article-id pub-id-type="other">00310</article-id>
      <article-id pub-id-type="doi">10.36660/abc.20230699</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigo Original</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Associa&#231;&#227;o entre o Perfil Hemodin&#226;mico da Insufici&#234;ncia Card&#237;aca &#224; Admiss&#227;o Hospitalar e Mortalidade - Programa Boas Pr&#225;ticas Cl&#237;nicas em Cardiologia</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0009-0004-8073-9768</contrib-id>
          <name>
            <surname>Rodrigues</surname>
            <given-names>Andr&#233; Silva</given-names>
          </name>
          <role>Concep&#231;&#227;o e desenho da pesquisa</role>
          <role>Obten&#231;&#227;o de dados</role>
          <role>An&#225;lise e interpreta&#231;&#227;o dos dados</role>
          <role>An&#225;lise estat&#237;stica</role>
          <role>Reda&#231;&#227;o do manuscrito</role>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="c1"/>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-0489-3737</contrib-id>
          <name>
            <surname>Castilho</surname>
            <given-names>F&#225;bio Morato de</given-names>
          </name>
          <role>Concep&#231;&#227;o e desenho da pesquisa</role>
          <role>Obten&#231;&#227;o de dados</role>
          <role>An&#225;lise e interpreta&#231;&#227;o dos dados</role>
          <role>Reda&#231;&#227;o do manuscrito</role>
          <role>Revis&#227;o cr&#237;tica do manuscrito quanto ao conte&#250;do</role>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ribeiro</surname>
            <given-names>Aloisio Joaquim Freitas</given-names>
          </name>
          <role>An&#225;lise e interpreta&#231;&#227;o dos dados</role>
          <role>An&#225;lise estat&#237;stica</role>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0001-8260-9212</contrib-id>
          <name>
            <surname>Passaglia</surname>
            <given-names>Luiz Guilherme</given-names>
          </name>
          <role>Concep&#231;&#227;o e desenho da pesquisa</role>
          <role>Obten&#231;&#227;o de dados</role>
          <role>An&#225;lise e interpreta&#231;&#227;o dos dados</role>
          <role>Revis&#227;o cr&#237;tica do manuscrito quanto ao conte&#250;do</role>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0003-0674-5997</contrib-id>
          <name>
            <surname>Taniguchi</surname>
            <given-names>Fabio Papa</given-names>
          </name>
          <role>Concep&#231;&#227;o e desenho da pesquisa</role>
          <role>Obten&#231;&#227;o de dados</role>
          <role>Obten&#231;&#227;o de financiamento</role>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-2740-0042</contrib-id>
          <name>
            <surname>Ribeiro</surname>
            <given-names>Antonio L.</given-names>
          </name>
          <role>Concep&#231;&#227;o e desenho da pesquisa</role>
          <role>An&#225;lise e interpreta&#231;&#227;o dos dados</role>
          <role>Reda&#231;&#227;o do manuscrito</role>
          <role>Revis&#227;o cr&#237;tica do manuscrito quanto ao conte&#250;do</role>
          <xref ref-type="aff" rid="aff5">
            <sup>5</sup>
          </xref>
        </contrib>
        <aff id="aff1">
          <label>1</label>
          <institution content-type="orgname">Universidade Federal de Minas Gerais</institution>
          <institution content-type="orgdiv1">Servi&#231;o de Cardiologia HC</institution>
          <addr-line>
            <named-content content-type="city">Belo Horizonte</named-content>
            <named-content content-type="state">MG</named-content>
          </addr-line>
          <country country="BR">Brasil</country>
          <institution content-type="original">Universidade Federal de Minas Gerais - Servi&#231;o de Cardiologia HC- UFMG, Belo Horizonte, MG &#8211; Brasil</institution>
        </aff>
        <aff id="aff2">
          <label>2</label>
          <institution content-type="orgname">Universidade Federal de Minas Gerais</institution>
          <institution content-type="orgdiv1">Faculdade de Medicina</institution>
          <institution content-type="orgdiv2">Departamento de Cl&#237;nica M&#233;dica</institution>
          <addr-line>
            <named-content content-type="city">Belo Horizonte</named-content>
            <named-content content-type="state">MG</named-content>
          </addr-line>
          <country country="BR">Brasil</country>
          <institution content-type="original">Universidade Federal de Minas Gerais - Departamento de Cl&#237;nica M&#233;dica - Faculdade de Medicina &#8211; UFMG, Belo Horizonte, MG &#8211; Brasil</institution>
        </aff>
        <aff id="aff3">
          <label>3</label>
          <institution content-type="orgname">Universidade Federal de Minas Gerais</institution>
          <institution content-type="orgdiv1">Departamento de Estat&#237;stica</institution>
          <addr-line>
            <named-content content-type="city">Belo Horizonte</named-content>
            <named-content content-type="state">MG</named-content>
          </addr-line>
          <country country="BR">Brasil</country>
          <institution content-type="original">Universidade Federal de Minas Gerais - Departamento de Estat&#237;stica, Belo Horizonte, MG &#8211; Brasil</institution>
        </aff>
        <aff id="aff4">
          <label>4</label>
          <institution content-type="orgname">Hospital do Cora&#231;&#227;o</institution>
          <addr-line>
            <named-content content-type="city">S&#227;o Paulo</named-content>
            <named-content content-type="state">SP</named-content>
          </addr-line>
          <country country="BR">Brasil</country>
          <institution content-type="original">Hospital do Cora&#231;&#227;o, S&#227;o Paulo, SP &#8211; Brasil</institution>
        </aff>
        <aff id="aff5">
          <label>5</label>
          <institution content-type="orgname">Universidade Federal de Minas Gerais</institution>
          <institution content-type="orgdiv1">Centro de Telessa&#250;de</institution>
          <institution content-type="orgdiv2">Hospital das Cl&#237;nicas</institution>
          <addr-line>
            <named-content content-type="city">Belo Horizonte</named-content>
            <named-content content-type="state">MG</named-content>
          </addr-line>
          <country country="BR">Brasil</country>
          <institution content-type="original">Universidade Federal de Minas Gerais - Centro de Telessa&#250;de - Hospital das Cl&#237;nicas &#8211; UFMG, Belo Horizonte, MG &#8211; Brasil</institution>
        </aff>
      </contrib-group>
      <author-notes>
        <corresp id="c1"><bold>Correspond&#234;ncia: Andr&#233; Silva Rodrigues</bold> &#8226; Universidade Federal de Minas Gerais - Servi&#231;o de Cardiologia HC- UFMG - Hospital das Cl&#237;nicas - UFMG - Avenida Alfreno Balena, 110. CEP <postal-code>30130-100</postal-code>, Bairro Santa Efig&#234;nia, Belo Horizonte, MG - Brasil E-mail: <email>andresilva90@gmail.com</email> </corresp>
        <fn fn-type="edited-by">
          <p>Editor respons&#225;vel pela revis&#227;o: Gl&#225;ucia Maria Moraes de Oliveira</p>
        </fn>
        <fn fn-type="conflict">
          <p>
            <bold>Potencial conflito de interesse</bold>
          </p>
          <p>N&#227;o h&#225; conflito com o presente artigo</p>
        </fn>
      </author-notes>
      <pub-date date-type="pub" publication-format="electronic">
        <day>24</day>
        <month>06</month>
        <year>2024</year>
      </pub-date>
      <pub-date date-type="collection" publication-format="electronic">
        <year>2024</year>
      </pub-date>
      <volume>121</volume>
      <issue>5</issue>
      <elocation-id>e20230699</elocation-id>
      <history>
        <date date-type="received">
          <day>10</day>
          <month>10</month>
          <year>2023</year>
        </date>
        <date date-type="rev-recd">
          <day>28</day>
          <month>12</month>
          <year>2023</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>02</month>
          <year>2024</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xml:lang="en">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License</license-p>
        </license>
      </permissions>
      <abstract>
        <title>Resumo</title>
        <sec>
          <title>Fundamento:</title>
          <p>A insufici&#234;ncia card&#237;aca (IC) &#233; respons&#225;vel por alta carga de interna&#231;&#245;es hospitalares. A sua forma de apresenta&#231;&#227;o est&#225; relacionada ao progn&#243;stico da doen&#231;a.</p>
        </sec>
        <sec>
          <title>Objetivos:</title>
          <p>Descrever a associa&#231;&#227;o entre o perfil hemodin&#226;mico de admiss&#227;o hospitalar na IC aguda, baseado em congest&#227;o (&#250;mido ou seco) e perfus&#227;o (frio ou quente), e desfechos de mortalidade, tempo de interna&#231;&#227;o e chance de reinterna&#231;&#227;o.</p>
        </sec>
        <sec>
          <title>M&#233;todos:</title>
          <p>Estudo de coorte, envolvendo pacientes do projeto "Boas Pr&#225;ticas Cl&#237;nicas em Cardiologia", internados por IC aguda em hospitais p&#250;blicos brasileiros, entre mar&#231;o de 2016 a dezembro de 2019, com seguimento de seis meses. Foram realizadas an&#225;lises das caracter&#237;sticas populacionais e do perfil hemodin&#226;mico de admiss&#227;o, al&#233;m de an&#225;lises de sobreviv&#234;ncia pelos modelos de Cox para associa&#231;&#227;o entre o perfil de admiss&#227;o e mortalidade, e regress&#227;o log&#237;stica para chance de reinterna&#231;&#227;o, considerando n&#237;vel de signific&#226;ncia estat&#237;stica de 5%.</p>
        </sec>
        <sec>
          <title>Resultados:</title>
          <p>Foram avaliados 1978 pacientes, com idade m&#233;dia foi 60,2 (&#177;14,8) anos e fra&#231;&#227;o de eje&#231;&#227;o m&#233;dia do ventr&#237;culo esquerdo de 39,8% (&#177;17,3%). Houve altas taxas de mortalidade no seguimento de seis meses (22%), com associa&#231;&#227;o entre os perfis hemodin&#226;micos frios e a mortalidade hospitalar (HR=1,72; IC95% 1,27-2,31; p &lt; 0,001) e em 6 meses (HR= 1,61, IC 95% 1,29-2,02). A taxa de reinterna&#231;&#227;o em 6 meses foi de 22%, sendo maior para os pacientes admitidos em perfis &#250;midos (OR 2,30; IC95% 1,45-3,65; p &lt; 0,001).</p>
        </sec>
        <sec>
          <title>Conclus&#245;es:</title>
          <p>A IC aguda no Brasil apresenta altas taxas de mortalidade e reinterna&#231;&#245;es e os perfis hemodin&#226;micos de admiss&#227;o hospitalar s&#227;o bons marcadores progn&#243;sticos dessa evolu&#231;&#227;o.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="pt">
        <title>Palavras-chave:</title>
        <kwd>Insufici&#234;ncia Card&#237;aca</kwd>
        <kwd>Mortalidade</kwd>
        <kwd>Hospitaliza&#231;&#227;o</kwd>
      </kwd-group>
      <counts>
        <fig-count count="2"/>
        <table-count count="6"/>
        <equation-count count="0"/>
        <ref-count count="20"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introdu&#231;&#227;o</title>
      <p>A insufici&#234;ncia card&#237;aca (IC) &#233; uma s&#237;ndrome complexa, respons&#225;vel por alta carga de interna&#231;&#245;es hospitalares e mortalidade. &#201; a principal causa de hospitaliza&#231;&#227;o entre as doen&#231;as cardiovasculares no Brasil, totalizando mais de tr&#234;s milh&#245;es nos &#250;ltimos 10 anos.&#185; A taxa de mortalidade hospitalar de pacientes internados por IC aguda no Brasil ainda &#233; muito elevada, atingindo 12,6% no registro BREATHE<sup><xref ref-type="bibr" rid="B2">2</xref></sup> de 2015.</p>
      <p>Registros internacionais trazem taxas de mortalidade menores, sendo de 5,5% no contexto intra-hospitalar e de 26,7% em um ano ap&#243;s a alta hospitalar, na Europa.<sup><xref ref-type="bibr" rid="B3">3</xref></sup> No grande registro americano ADHERE,<sup><xref ref-type="bibr" rid="B4">4</xref></sup> a mortalidade hospitalar m&#233;dia no cen&#225;rio de IC aguda foi de 3,5%. H&#225; diferen&#231;as nessas taxas ao se avaliar as caracter&#237;sticas cl&#237;nicas de perfus&#227;o e congest&#227;o &#224; admiss&#227;o hospitalar, com aumento de at&#233; 66% na probabilidade de &#243;bito em um ano nos pacientes com perfil frio-&#250;mido em rela&#231;&#227;o aos com perfil quente-seco.<sup><xref ref-type="bibr" rid="B5">5</xref></sup></p>
      <p>A avalia&#231;&#227;o cl&#237;nica de perfus&#227;o (press&#227;o arterial, press&#227;o de pulso, perfus&#227;o perif&#233;rica, sens&#243;rio) e congest&#227;o (press&#227;o venosa jugular aumentada, ortopneia, edema, B3) define o perfil hemodin&#226;mico do paciente: quente-seco, quente-&#250;mido, frio-seco e frio-&#250;mido, que se relaciona com a gravidade de evolu&#231;&#227;o do quadro e progn&#243;stico da doen&#231;a.<sup><xref ref-type="bibr" rid="B6">6</xref></sup> Tal classifica&#231;&#227;o foi inicialmente descrita por Diamond-Forrester<sup><xref ref-type="bibr" rid="B7">7</xref></sup> em 1976, para pacientes p&#243;s-infarto agudo do mioc&#225;rdio. No contexto de IC, Stevenson LW<sup><xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref></sup> publicou diversos trabalhos sobre a import&#226;ncia do reconhecimento dos sinais cl&#237;nicos de congest&#227;o e hipoperfus&#227;o nos pacientes internados com IC aguda para terapia guiada por perfil hemodin&#226;mico, priorizando a diureticoterapia e vasodilata&#231;&#227;o naqueles pacientes &#250;midos e inotr&#243;picos para os pacientes frios.<sup><xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref></sup></p>
      <p>Espera-se que o perfil hemodin&#226;mico de admiss&#227;o seja um bom marcador progn&#243;stico da IC aguda no Brasil e ajude a caracterizar o atual comportamento dessa doen&#231;a no pa&#237;s. Ao se associar os perfis de admiss&#227;o com desfechos de mortalidade e risco de reinterna&#231;&#227;o, interven&#231;&#245;es espec&#237;ficas para cada perfil podem ser empregadas para melhoria dos resultados.</p>
    </sec>
    <sec>
      <title>Objetivos</title>
      <p>O objetivo do estudo foi demonstrar associa&#231;&#227;o entre o perfil hemodin&#226;mico de admiss&#227;o hospitalar com desfechos cardiovasculares maiores: mortalidade geral intra-hospitalar (desfecho prim&#225;rio) e mortalidade geral em at&#233; 6 meses (hospitalar e seguimento); tempo de interna&#231;&#227;o hospitalar e taxa de reinterna&#231;&#227;o em 6 meses (desfechos secund&#225;rios).</p>
    </sec>
    <sec sec-type="methods">
      <title>M&#233;todos</title>
      <p>Trata-se de estudo de coorte, envolvendo pacientes admitidos por IC aguda em 17 hospitais p&#250;blicos brasileiros, no per&#237;odo de mar&#231;o de 2016 a dezembro de 2019. Os centros s&#227;o hospitais terci&#225;rios de todas as regi&#245;es brasileiras e participantes do programa Boas Pr&#225;ticas Cl&#237;nicas em Cardiologia (BPC), da Sociedade Brasileira de Cardiologia (SBC). O BPC &#233; inspirado na iniciativa <italic>Get With The Guidelines</italic> (GWTG) da <italic>American Heart Association</italic> (AHA) e tem como objetivo principal a avalia&#231;&#227;o das taxas de ades&#227;o aos indicadores de desempenho recomendados pelas diretrizes brasileira e americana de cardiologia. O desenho e resultados do programa est&#227;o descritos em publica&#231;&#245;es anteriores.<sup><xref ref-type="bibr" rid="B10">10</xref>-<xref ref-type="bibr" rid="B12">12</xref></sup></p>
      <sec>
        <title>Popula&#231;&#227;o</title>
        <p>Foram inclu&#237;dos os pacientes com 18 anos ou mais admitidos com quadro IC aguda (CID-10 I50; I50.0; I50.1 ou I50.9) nos hospitais participantes. Foram exclu&#237;dos os pacientes com proposta de transfer&#234;ncia ou interna&#231;&#227;o prevista menor que 24 horas, al&#233;m daqueles com outra causa prov&#225;vel para dispneia, mesmo sendo portadores de IC.</p>
      </sec>
      <sec>
        <title>Coleta de dados</title>
        <p>Os dados apresentados foram coletados de forma prospectiva durante a interna&#231;&#227;o, usando prontu&#225;rio eletr&#244;nico e formul&#225;rios pr&#243;prios, e em 30 dias e seis meses ap&#243;s a alta por meio de contato telef&#244;nico feito por entrevistadores treinados. O Termo de Consentimento Livre e Esclarecido foi assinado por todos os participantes e o estudo foi aprovado pelo Comit&#234; de &#201;tica do centro coordenador- HCor S&#227;o Paulo (sob o n&#250;mero 48561715.5.1001.0060) e no Comit&#234; de &#201;tica do Hospital das Cl&#237;nicas da UFMG (sob o n&#250;mero 1.487.029).</p>
      </sec>
      <sec>
        <title>Perfis hemodin&#226;micos</title>
        <p>O perfil hemodin&#226;mico foi definido por avalia&#231;&#227;o cl&#237;nica do m&#233;dico respons&#225;vel pela admiss&#227;o do paciente, sendo classificado em quente-seco (sem sinais de descompensa&#231;&#227;o); quente-&#250;mido (boa perfus&#227;o, mas congesto); frio-seco (m&#225; perfus&#227;o perif&#233;rica, mas sem congest&#227;o); frio-&#250;mido (m&#225; perfus&#227;o e congesto). Nessa classifica&#231;&#227;o em quatro categorias, os n&#237;veis de exposi&#231;&#227;o definidores s&#227;o dois: perfus&#227;o (frio ou quente) e congest&#227;o (&#250;mido ou seco). Baseado nisso, foram feitas an&#225;lises de sobreviv&#234;ncia e multivariadas para estimar os riscos para os desfechos de interesse para os quatro perfis cl&#225;ssicos, bem como para os padr&#245;es de perfus&#227;o (perfis frios x perfis quentes) e de congest&#227;o (perfis &#250;midos x perfis secos).</p>
      </sec>
      <sec>
        <title>An&#225;lise estat&#237;stica</title>
        <p>Na an&#225;lise descritiva das vari&#225;veis de desfecho e das covari&#225;veis de interesse por perfil hemodin&#226;mico, as vari&#225;veis cont&#237;nuas foram descritas pela m&#233;dia &#177; desvio padr&#227;o ou pela mediana e faixa interquart&#237;lica (Q1 e Q3) conforme normalidade dos dados (teste Shapiro Wilk) e as vari&#225;veis categ&#243;ricas foram descritas por suas frequ&#234;ncias absoluta e relativa. Os perfis hemodin&#226;micos foram comparados pelo teste qui-quadrado (vari&#225;veis categ&#243;ricas) e pelo teste de Kruskal- Wallis (vari&#225;veis quantitativas). Compara&#231;&#245;es m&#250;ltiplas foram realizadas pelo teste de Dunn (vari&#225;veis quantitativas) e teste Z para duas propor&#231;&#245;es (vari&#225;veis categ&#243;ricas), com corre&#231;&#227;o pelo m&#233;todo de Holm, pelo pacote rstatix do software R.</p>
        <p>Foram constru&#237;das curvas de sobreviv&#234;ncia pelo m&#233;todo de Kaplan Meier, por an&#225;lise univariada, para avaliar o efeito do perfil hemodin&#226;mico (em quatro e duas categorias) de admiss&#227;o na mortalidade durante o seguimento do estudo - per&#237;odo de seis meses (teste de log-rank). O grupo de refer&#234;ncia para estimativa dos riscos e chances foi o grupo quente-seco.</p>
        <p>O modelo de riscos proporcionais de Cox foi utilizado para investigar a influ&#234;ncia dos perfis hemodin&#226;micos sobre a mortalidade durante a interna&#231;&#227;o e sobre a mortalidade no seguimento de seis meses, controlando o efeito das vari&#225;veis idade, sexo, presen&#231;a de comorbidades avaliadas &#224; admiss&#227;o hospitalar e fra&#231;&#227;o de eje&#231;&#227;o do ventr&#237;culo esquerdo (FEVE), de forma incremental. Para avaliar a influ&#234;ncia dos perfis hemodin&#226;micos sobre a ocorr&#234;ncia de pelo menos uma reinterna&#231;&#227;o no seguimento de seis meses, utilizou-se modelos de regress&#227;o log&#237;stica, com as mesmas vari&#225;veis de controle do modelo de Cox, al&#233;m do tempo de seguimento dos pacientes ap&#243;s a alta.</p>
        <p>O n&#237;vel de signific&#226;ncia adotado na an&#225;lise estat&#237;stica foi de 5%. Todas as an&#225;lises estat&#237;sticas foram realizadas nos pacotes <italic>stats, rstatix, survival, survminer, e mice</italic> do <italic>software</italic> R (R Core Team, 2020).</p>
      </sec>
      <sec>
        <title>Falta de dados e tratamento das perdas</title>
        <p>O perfil hemodin&#226;mico de 784 (28%) pacientes n&#227;o foi informado, e eles foram exclu&#237;dos do estudo. A compara&#231;&#227;o dos grupos com e sem informa&#231;&#227;o sobre o perfil hemodin&#226;mico quanto ao desfecho prim&#225;rio (morte durante a interna&#231;&#227;o) n&#227;o revelou diferen&#231;a significativa entre eles (p-valor = 0,08; <xref ref-type="app" rid="app1">Tabela 1 do material suplementar</xref>), evidenciando a validade da suposi&#231;&#227;o de perda aleat&#243;ria dessa informa&#231;&#227;o.</p>
        <p>Entre os pacientes com informa&#231;&#245;es v&#225;lidas sobre o perfil hemodin&#226;mico, 96 possu&#237;am informa&#231;&#227;o faltante para a vari&#225;vel FEVE. Os valores faltantes para essa vari&#225;vel foram imputados pelo m&#233;todo de imputa&#231;&#227;o m&#250;ltipla, pmm (<italic>predictive mean matching</italic>) dispon&#237;vel no pacote MICE (Multivariate Imputation by Chained Equation) do software R,<sup><xref ref-type="bibr" rid="B13">13</xref></sup> resultando em 10 conjuntos de dados completos. Nesse modelo de imputa&#231;&#227;o dos valores de FEVE, foram utilizadas as vari&#225;veis sexo, idade, presen&#231;a de comorbidades, perfil hemodin&#226;mico e uma estimativa do risco de morte durante a interna&#231;&#227;o obtida pelo m&#233;todo de Nelson Aalen. Um total de 679 pacientes n&#227;o apresentavam dados sobre uso de medicamentos. Como essas vari&#225;veis foram utilizadas apenas para a descri&#231;&#227;o da amostra, seus valores n&#227;o foram imputados.</p>
        <p>Para o desfecho secund&#225;rio de reinterna&#231;&#227;o em seis meses, foram avaliados 1543 participantes, que s&#227;o 1.758 sobreviventes menos 215 participantes que n&#227;o tiveram dois contatos telef&#244;nicos efetivos nesse per&#237;odo (12% de perda de seguimento).</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Resultados</title>
      <sec>
        <title>Descri&#231;&#227;o da amostra &#224; admiss&#227;o</title>
        <p>Dos 2.762 pacientes inclu&#237;dos na coorte at&#233; 2019, foram analisados os dados de 1.978 que tinham a informa&#231;&#227;o do perfil hemodin&#226;mico em prontu&#225;rio. Os dados basais est&#227;o apresentados na <xref ref-type="table" rid="t1">Tabela 1</xref>, estratificados pelo perfil hemodin&#226;mico de admiss&#227;o. A popula&#231;&#227;o estudada tem idade m&#233;dia de 60 anos, sendo a maioria dos pacientes do g&#234;nero masculino, de baixa escolaridade (65% analfabetos ou com ensino fundamental) e baixa renda (73,2% com at&#233; dois sal&#225;rios-m&#237;nimos de renda familiar mensal). As comorbidades mais relatadas pelos pacientes &#224; admiss&#227;o foram hipertens&#227;o arterial, diabetes mellitus e fibrila&#231;&#227;o atrial.</p>
        <table-wrap id="t1">
          <label>Tabela 1</label>
          <caption>
            <title>Caracter&#237;sticas basais dos pacientes, estratificadas pelo perfil hemodin&#226;mico</title>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup width="16%">
              <col/>
              <col/>
              <col/>
              <col/>
              <col/>
              <col/>
            </colgroup>
            <thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
              <tr style="background-color:#78B2CB;">
                <th align="left" valign="middle">Caracter&#237;sticas basais</th>
                <th align="center" valign="middle">Total (N=1978)</th>
                <th align="center" valign="middle">Quente-seco (n=183)</th>
                <th align="center" valign="middle">Quente-&#250;mido (n=1435)</th>
                <th align="center" valign="middle">Frio-&#250;mido (n=298)</th>
                <th align="center" valign="middle">Frio-seco (n=62)</th>
              </tr>
            </thead>
            <tbody style="border-bottom: thin solid; border-color: #000000">
              <tr style="background-color:#1;">
                <td align="left" valign="top">G&#234;nero masculino<xref ref-type="table-fn" rid="TFN1">*</xref> - n (%)</td>
                <td align="center" valign="top">1154 (58,3)</td>
                <td align="center" valign="top">91 (49,7)</td>
                <td align="center" valign="top">832 (58)</td>
                <td align="center" valign="top">191 (64,1)</td>
                <td align="center" valign="top">40 (64,5)</td>
              </tr>
              <tr style="background-color:#C5DDEA;">
                <td align="left" valign="top">Idade m&#233;dia (DP)</td>
                <td align="center" valign="top">60,2 (14,8)</td>
                <td align="center" valign="top">54,8 (16,7)</td>
                <td align="center" valign="top">61,1 (14,4)</td>
                <td align="center" valign="top">59,2 (14,9)</td>
                <td align="center" valign="top">61,8 (14,4)</td>
              </tr>
              <tr style="background-color:#1;">
                <td align="left" valign="top">
                  <bold>Escolaridade</bold>
                  <xref ref-type="table-fn" rid="TFN1">*</xref>
                  <bold>- n (%)</bold>
                </td>
                <td align="center" valign="top"/>
                <td align="center" valign="top"/>
                <td align="center" valign="top"/>
                <td align="center" valign="top"/>
                <td align="center" valign="top"/>
              </tr>
              <tr style="background-color:#2;">
                <td align="left" valign="top">Analfabeto</td>
                <td align="center" valign="top">192 (9,7)</td>
                <td align="center" valign="top">16 (8,7)</td>
                <td align="center" valign="top">152 (10,6)</td>
                <td align="center" valign="top">21 (7)</td>
                <td align="center" valign="top">3 (4,8)</td>
              </tr>
              <tr style="background-color:#1;">
                <td align="left" valign="top">Ensino Fundamental</td>
                <td align="center" valign="top">1094 (55,3)</td>
                <td align="center" valign="top">85 (46,4)</td>
                <td align="center" valign="top">817 (56,9)</td>
                <td align="center" valign="top">157 (52,7)</td>
                <td align="center" valign="top">35 (56,5)</td>
              </tr>
              <tr style="background-color:#2;">
                <td align="left" valign="top">Ensino M&#233;dio</td>
                <td align="center" valign="top">519 (26,2)</td>
                <td align="center" valign="top">65 (35,5)</td>
                <td align="center" valign="top">353 (24,6)</td>
                <td align="center" valign="top">81 (27,2)</td>
                <td align="center" valign="top">20 (32,3)</td>
              </tr>
              <tr style="background-color:#1;">
                <td align="left" valign="top">Ensino Superior</td>
                <td align="center" valign="top">169 (8,5)</td>
                <td align="center" valign="top">17 (9,3)</td>
                <td align="center" valign="top">112 (7,8)</td>
                <td align="center" valign="top">36 (12,1)</td>
                <td align="center" valign="top">4 (6,5)</td>
              </tr>
              <tr style="background-color:#C5DDEA;">
                <td align="left" valign="top">
                  <bold>Renda familiar</bold>
                  <xref ref-type="table-fn" rid="TFN1">*</xref>
                  <bold>- n (%)</bold>
                </td>
                <td align="center" valign="top"/>
                <td align="center" valign="top"/>
                <td align="center" valign="top"/>
                <td align="center" valign="top"/>
                <td align="center" valign="top"/>
              </tr>
              <tr style="background-color:#C5DDEA;">
                <td align="left" valign="top">&lt;1 sal&#225;rio-m&#237;nimo (U$ 270)</td>
                <td align="center" valign="top">656 (33,2)</td>
                <td align="center" valign="top">82 (44,8)</td>
                <td align="center" valign="top">467 (32,5)</td>
                <td align="center" valign="top">93 (31,2)</td>
                <td align="center" valign="top">14 (22,6)</td>
              </tr>
              <tr style="background-color:#C5DDEA;">
                <td align="left" valign="top">1 a 2 sal&#225;rios (U$ 270- 540)</td>
                <td align="center" valign="top">792 (40)</td>
                <td align="center" valign="top">53 (29)</td>
                <td align="center" valign="top">608 (42,4)</td>
                <td align="center" valign="top">108 (36,2)</td>
                <td align="center" valign="top">23 (37,1)</td>
              </tr>
              <tr style="background-color:#C5DDEA;">
                <td align="left" valign="top">2 a 5 sal&#225;rios (U$ 540- 1350)</td>
                <td align="center" valign="top">433 (21,9)</td>
                <td align="center" valign="top">39 (21,3)</td>
                <td align="center" valign="top">301 (21)</td>
                <td align="center" valign="top">71 (23,8)</td>
                <td align="center" valign="top">22 (35,5)</td>
              </tr>
              <tr style="background-color:#C5DDEA;">
                <td align="left" valign="top">&gt; 5 sal&#225;rios (&gt; U$ 540)</td>
                <td align="center" valign="top">90 (4,6)</td>
                <td align="center" valign="top">8 (4,4)</td>
                <td align="center" valign="top">57 (4)</td>
                <td align="center" valign="top">22 (7,4)</td>
                <td align="center" valign="top">3 (4,8)</td>
              </tr>
              <tr style="background-color:#1;">
                <td align="left" valign="top">
                  <bold>Comorbidades autodeclaradas - n (%)</bold>
                </td>
                <td align="center" valign="top"/>
                <td align="center" valign="top"/>
                <td align="center" valign="top"/>
                <td align="center" valign="top"/>
                <td align="center" valign="top"/>
              </tr>
              <tr style="background-color:#2;">
                <td align="left" valign="top">Hipertens&#227;o arterial<xref ref-type="table-fn" rid="TFN1">*</xref> </td>
                <td align="center" valign="top">1351(68,3)</td>
                <td align="center" valign="top">111 (60,7)</td>
                <td align="center" valign="top">1028 (71,6)</td>
                <td align="center" valign="top">178 (59,7)</td>
                <td align="center" valign="top">34 (54,8)</td>
              </tr>
              <tr style="background-color:#1;">
                <td align="left" valign="top">Diabetes mellitus</td>
                <td align="center" valign="top">652 (33)</td>
                <td align="center" valign="top">48 (26,2)</td>
                <td align="center" valign="top">497 (34,6)</td>
                <td align="center" valign="top">92 (30,9)</td>
                <td align="center" valign="top">15 (24,2)</td>
              </tr>
              <tr style="background-color:#2;">
                <td align="left" valign="top">Doen&#231;a de Chagas<xref ref-type="table-fn" rid="TFN1">*</xref> </td>
                <td align="center" valign="top">208 (10,5)</td>
                <td align="center" valign="top">12 (6,6)</td>
                <td align="center" valign="top">135 (9,4)</td>
                <td align="center" valign="top">51 (17,1)</td>
                <td align="center" valign="top">10 (16,1)</td>
              </tr>
              <tr style="background-color:#1;">
                <td align="left" valign="top">Doen&#231;a coronariana</td>
                <td align="center" valign="top">285 (14,4)</td>
                <td align="center" valign="top">20 (10,9)</td>
                <td align="center" valign="top">217 (15,1)</td>
                <td align="center" valign="top">42 (14,1)</td>
                <td align="center" valign="top">6 (9,7)</td>
              </tr>
              <tr style="background-color:#2;">
                <td align="left" valign="top">Fibrila&#231;&#227;o/ flutter atrial <xref ref-type="table-fn" rid="TFN1">*</xref> </td>
                <td align="center" valign="top">503 (25,4)</td>
                <td align="center" valign="top">30 (16,4)</td>
                <td align="center" valign="top">375 (26,1)</td>
                <td align="center" valign="top">75 (25,2)</td>
                <td align="center" valign="top">23 (37,1)</td>
              </tr>
              <tr style="background-color:#1;">
                <td align="left" valign="top">Doen&#231;a renal cr&#244;nica<xref ref-type="table-fn" rid="TFN1">*</xref> </td>
                <td align="center" valign="top">309 (15,6)</td>
                <td align="center" valign="top">8 (4,4)</td>
                <td align="center" valign="top">227 (15,8)</td>
                <td align="center" valign="top">60 (20,1)</td>
                <td align="center" valign="top">14 (22,6)</td>
              </tr>
              <tr style="background-color:#C5DDEA;">
                <td align="left" valign="top">
                  <bold>Classe funcional</bold>
                  <xref ref-type="table-fn" rid="TFN1">*</xref>
                  <bold>n (%)</bold>
                </td>
                <td align="center" valign="top"/>
                <td align="center" valign="top"/>
                <td align="center" valign="top"/>
                <td align="center" valign="top"/>
                <td align="center" valign="top"/>
              </tr>
              <tr style="background-color:#C5DDEA;">
                <td align="left" valign="top">I-II</td>
                <td align="center" valign="top">208 (10,5)</td>
                <td align="center" valign="top">67 (36,6)</td>
                <td align="center" valign="top">114 (7,9)</td>
                <td align="center" valign="top">18 (6)</td>
                <td align="center" valign="top">9 (14,5)</td>
              </tr>
              <tr style="background-color:#C5DDEA;">
                <td align="left" valign="top">III-IV</td>
                <td align="center" valign="top">1393 (70,4)</td>
                <td align="center" valign="top">102 (55,7)</td>
                <td align="center" valign="top">1032 (71,9)</td>
                <td align="center" valign="top">212 (71,1)</td>
                <td align="center" valign="top">47 (75,8)</td>
              </tr>
              <tr style="background-color:#C5DDEA;">
                <td align="left" valign="top">n&#227;o informada</td>
                <td align="center" valign="top">377 (19,1)</td>
                <td align="center" valign="top">14 (7,7)</td>
                <td align="center" valign="top">289 (20,1)</td>
                <td align="center" valign="top">68 (22,8)</td>
                <td align="center" valign="top">6 (9,7)</td>
              </tr>
              <tr style="background-color:#C5DDEA;">
                <td align="left" valign="top">
                  <bold>Fra&#231;&#227;o de eje&#231;&#227;o</bold>
                  <xref ref-type="table-fn" rid="TFN1">*</xref>
                  <bold>n (%)</bold>
                </td>
                <td align="center" valign="top"/>
                <td align="center" valign="top"/>
                <td align="center" valign="top"/>
                <td align="center" valign="top"/>
                <td align="center" valign="top"/>
              </tr>
              <tr style="background-color:#C5DDEA;">
                <td align="left" valign="top">&gt; 50%</td>
                <td align="center" valign="top">509 (25,7)</td>
                <td align="center" valign="top">77 (42,1)</td>
                <td align="center" valign="top">383 (26,7)</td>
                <td align="center" valign="top">37 (12,4)</td>
                <td align="center" valign="top">12 (19,4)</td>
              </tr>
              <tr style="background-color:#C5DDEA;">
                <td align="left" valign="top">41-50%</td>
                <td align="center" valign="top">232 (11,7)</td>
                <td align="center" valign="top">24 (13,1)</td>
                <td align="center" valign="top">173 (12,1)</td>
                <td align="center" valign="top">23 (7,7)</td>
                <td align="center" valign="top">12 (19,4)</td>
              </tr>
              <tr style="background-color:#C5DDEA;">
                <td align="left" valign="top">&#8804; 40%</td>
                <td align="center" valign="top">1135 (57,4)</td>
                <td align="center" valign="top">66 (36,1)</td>
                <td align="center" valign="top">808 (56,3)</td>
                <td align="center" valign="top">224 (59,7)</td>
                <td align="center" valign="top">37 (59,7)</td>
              </tr>
              <tr style="background-color:#C5DDEA;">
                <td align="left" valign="top">Insufici&#234;ncia card&#237;aca pr&#233;via - n (%)</td>
                <td align="center" valign="top">1578 (79,8)</td>
                <td align="center" valign="top">147 (80,3)</td>
                <td align="center" valign="top">1131 (78,9)</td>
                <td align="center" valign="top">243 (81,5)</td>
                <td align="center" valign="top">57 (79,8)</td>
              </tr>
              <tr style="background-color:#C5DDEA;">
                <td align="left" valign="top">Interna&#231;&#245;es &#250;ltimos 6 meses<xref ref-type="table-fn" rid="TFN1">*</xref>- n (%)</td>
                <td align="center" valign="top">651 (32,9)</td>
                <td align="center" valign="top">65 (35,5)</td>
                <td align="center" valign="top">444 (30,9)</td>
                <td align="center" valign="top">124 (41,7)</td>
                <td align="center" valign="top">18 (29,1)</td>
              </tr>
              <tr style="background-color:#2;">
                <td align="left" valign="top">
                  <bold>Medicamentos de uso Pr&#233;vio - n (%)</bold>
                  <xref ref-type="table-fn" rid="TFN2">&#8224;</xref>
                </td>
                <td align="center" valign="top"/>
                <td align="center" valign="top"/>
                <td align="center" valign="top"/>
                <td align="center" valign="top"/>
                <td align="center" valign="top"/>
              </tr>
              <tr style="background-color:#1;">
                <td align="left" valign="top">Betabloqueador<xref ref-type="table-fn" rid="TFN1">*</xref> </td>
                <td align="center" valign="top">926 (71,3)</td>
                <td align="center" valign="top">75 (61)</td>
                <td align="center" valign="top">676 (71)</td>
                <td align="center" valign="top">147 (77)</td>
                <td align="center" valign="top">28 (84,8)</td>
              </tr>
              <tr style="background-color:#2;">
                <td align="left" valign="top">IECA ou BRA</td>
                <td align="center" valign="top">854 (65,7)</td>
                <td align="center" valign="top">80 (65)</td>
                <td align="center" valign="top">616 (64,7)</td>
                <td align="center" valign="top">137 (71,7)</td>
                <td align="center" valign="top">21 (63,6)</td>
              </tr>
              <tr style="background-color:#1;">
                <td align="left" valign="top">Espironolactona<xref ref-type="table-fn" rid="TFN1">*</xref> </td>
                <td align="center" valign="top">524 (40,3)</td>
                <td align="center" valign="top">45 (36,6)</td>
                <td align="center" valign="top">348 (36,6)</td>
                <td align="center" valign="top">109 (57,1)</td>
                <td align="center" valign="top">22 (66,7)</td>
              </tr>
              <tr style="background-color:#2;">
                <td align="left" valign="top">Diur&#233;tico de al&#231;a<xref ref-type="table-fn" rid="TFN1">*</xref> </td>
                <td align="center" valign="top">885 (68,1)</td>
                <td align="center" valign="top">72 (58,5)</td>
                <td align="center" valign="top">648 (68,1)</td>
                <td align="center" valign="top">137 (71,7)</td>
                <td align="center" valign="top">28 (84,8)</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="TFN1">
              <label>*</label>
              <p>p valor &lt; 0,05 para diferen&#231;a entre os perfis hemodin&#226;micos (teste qui-quadrado).</p>
            </fn>
            <fn id="TFN2">
              <label>&#8224;</label>
              <p>N= 1299 por perda de dados sobre o uso de medica&#231;&#245;es pr&#233;vias;</p>
            </fn>
            <fn id="TFN2a">
              <p>IECA: inibidor da enzima conversora de angiotensina; BRA: bloqueador do receptor de angiotensina.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>A maioria dos pacientes j&#225; apresentava diagn&#243;stico pr&#233;vio de IC (IC descompensada) e estava em classe funcional III-IV (<italic>New York Heart Association</italic>, NYHA). As etiologias mais frequentes encontradas na interna&#231;&#227;o (ap&#243;s a realiza&#231;&#245;es de exames e defini&#231;&#227;o pela equipe assistente) foram idiop&#225;tica (23,3%); isqu&#234;mica (21,3%); hipertensiva (16,1%); valvar (15,3%) e cardiomiopatia chag&#225;sica (9,9%), dentre outras (14,1%). (<xref ref-type="app" rid="app1">Tabela 2 do material suplementar</xref>). A maioria dos pacientes do estudo apresentava IC com FEVE (&#8804; 40%), com valor m&#233;dio de 39,8% (&#177;17,3%) e o perfil hemodin&#226;mico mais frequente na admiss&#227;o foi o quente-&#250;mido.</p>
      </sec>
      <sec>
        <title>An&#225;lise univariada dos desfechos de interesse</title>
        <p>Houve 220 &#243;bitos intra-hospitalares, o que corresponde &#224; uma mortalidade geral de 11,1% da amostra. Essa mortalidade foi maior nos pacientes admitidos com baixa perfus&#227;o perif&#233;rica (perfis frios), sendo de 21,5% no perfil frio-&#250;mido e 14,5% no perfil frio-seco. Apenas 10 pacientes (0,5% da amostra) realizaram transplante card&#237;aco na interna&#231;&#227;o. Durante o per&#237;odo do estudo, que incluiu a interna&#231;&#227;o e o seguimento em seis meses, a taxa de mortalidade geral foi de 22%, sendo maior nos pacientes admitidos em perfil frio-&#250;mido, que apresentaram taxa de mortalidade geral de 32%. O tempo de interna&#231;&#227;o tamb&#233;m variou significativamente entre os perfis hemodin&#226;micos, sendo a mediana de 17 (9-33) dias na popula&#231;&#227;o geral e de 23 (13-42) dias no perfil frio- &#250;mido (<xref ref-type="table" rid="t2">Tabela 2</xref>).</p>
        <table-wrap id="t2">
          <label>Tabela 2</label>
          <caption>
            <title>Desfechos prim&#225;rios e secund&#225;rios, estratificados pelo perfil hemodin&#226;mico</title>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup width="14%">
              <col/>
              <col/>
              <col/>
              <col/>
              <col/>
              <col/>
              <col/>
            </colgroup>
            <thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
              <tr style="background-color:#78B2CB;">
                <th align="left" valign="middle">Desfechos</th>
                <th align="center" valign="middle">Total (N=1978)</th>
                <th align="center" valign="middle">Quente-seco Grupo 1 (n=183)</th>
                <th align="center" valign="middle">Quente-&#250;mido Grupo 2 (n=1435)</th>
                <th align="center" valign="middle">Frio-&#250;mido Grupo 3 (n=298)</th>
                <th align="center" valign="middle">Frio-seco Grupo 4 (n=62)</th>
                <th align="center" valign="middle">p-valor</th>
              </tr>
            </thead>
            <tbody style="border-bottom: thin solid; border-color: #000000">
              <tr>
                <td align="left" valign="top">&#211;bitos hospitalares N (%)</td>
                <td align="center" valign="top">220 (11,1)</td>
                <td align="center" valign="top">14 (7,7)</td>
                <td align="center" valign="top">133 (9,3)</td>
                <td align="center" valign="top">64 (21,5)</td>
                <td align="center" valign="top">9 (14,5)</td>
                <td align="center" valign="top">&lt;0,001 (1=2&#8800;3=4)</td>
              </tr>
              <tr style="background-color:#C5DDEA;">
                <td align="left" valign="top">&#211;bitos per&#237;odo total (interna&#231;&#227;o e 6 meses de seguimento)- N(%)</td>
                <td align="center" valign="top">432 (22)</td>
                <td align="center" valign="top">32 (16)</td>
                <td align="center" valign="top">290 (20)</td>
                <td align="center" valign="top">96 (32)</td>
                <td align="center" valign="top">14 (22)</td>
                <td align="center" valign="top">&lt;0,001 (1=2&#8800;3=4)</td>
              </tr>
              <tr>
                <td align="left" valign="top">Dias de interna&#231;&#227;o Mediana (intervalo interquartil)</td>
                <td align="center" valign="top">17 (9-33)</td>
                <td align="center" valign="top">22 (10-35)</td>
                <td align="center" valign="top">16 (8-30)</td>
                <td align="center" valign="top">23 (13-42)</td>
                <td align="center" valign="top">15 (10-32)</td>
                <td align="center" valign="top">&lt;0,001 (1&#8800;2=3=4)</td>
              </tr>
              <tr style="background-color:#C5DDEA;">
                <td align="left" valign="top">Reinterna&#231;&#227;o<xref ref-type="table-fn" rid="TFN3">*</xref>- N(%)</td>
                <td align="center" valign="top">334 (22)</td>
                <td align="center" valign="top">18 (11,5)</td>
                <td align="center" valign="top">262 (23)</td>
                <td align="center" valign="top">48 (23,8)</td>
                <td align="center" valign="top">6 (13)</td>
                <td align="center" valign="top">0,004 (1&#8800;2=3&#8800;4)</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="TFN3">
              <label>*</label>
              <p>N=1543 por perdas de seguimento (&#243;bitos na interna&#231;&#227;o e pacientes n&#227;o acompanhados no seguimento).</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>No seguimento de seis meses ap&#243;s a alta hospitalar, foram acompanhados 1543 pacientes com dois contatos telef&#244;nicos. Desses, 334 (22%) pacientes tiveram pelo menos uma reinterna&#231;&#227;o hospitalar e houve efeito significativo do perfil hemodin&#226;mico de admiss&#227;o hospitalar para esse desfecho. Nesse caso, a reinterna&#231;&#227;o foi mais frequente nos pacientes congestos (perfis &#250;midos), sendo 23% no grupo quente-&#250;mido e 23,8% no grupo frio-&#250;mido, e somente 11,5% no grupo quente-seco e 10,9% no grupo frio-seco (<xref ref-type="table" rid="t2">Tabela 2</xref>).</p>
        <p>Na an&#225;lise de sobrevida univariada pelas curvas de Kaplan Meier, houve associa&#231;&#227;o entre o perfil cl&#237;nico de admiss&#227;o e a mortalidade no per&#237;odo total (hospitalar e seguimento em 6 meses), com maior mortalidade do perfil frio-&#250;mido em rela&#231;&#227;o aos outros (p &lt; 0,0001, teste de log-rank). Ao se avaliar separadamente perfus&#227;o e congest&#227;o, nota-se que os perfis frios tiveram maior mortalidade no seguimento em compara&#231;&#227;o aos perfis quentes (p &lt; 0,0001, teste de log-rank), o que n&#227;o foi observado para os perfis &#250;midos versus secos, p = 0,08 (teste de log-rank). (<xref ref-type="fig" rid="f1">Figura Central</xref>).</p>
        <fig id="f1">
          <caption>
            <title>Curvas de Kaplan Meier em rela&#231;&#227;o &#224; mortalidade geral.</title>
          </caption>
          <graphic xlink:href="1678-4170-abc-121-05-e20230699-30699-gf01.tif"/></fig>
      </sec>
      <sec>
        <title>An&#225;lise multivariada</title>
        <p>Ao se comparar com o perfil de refer&#234;ncia quente-seco, os pacientes admitidos com perfil frio-&#250;mido apresentaram risco aumentado de &#243;bito na interna&#231;&#227;o (HR= 2,2, IC 95% 1,20-4,04), assim como perfil frio-seco (HR= 2,39; IC 95% 1,02-5,57). O perfil quente-&#250;mido, por sua vez, n&#227;o se associou ao aumento de risco de &#243;bito na interna&#231;&#227;o (HR= 1,33, IC 95% 0,76-2,33). No per&#237;odo de seguimento do estudo (at&#233; seis meses ap&#243;s a alta), esse risco aumentado de &#243;bito tamb&#233;m se manteve para o perfil frio-&#250;mido (HR= 1,96, IC 95% 1,3-3,0) (<xref ref-type="table" rid="t3">Tabela 3</xref>).</p>
        <table-wrap id="t3">
          <label>Tabela 3</label>
          <caption>
            <title>Riscos Relativos de &#243;bito estimados pelo Modelo de Cox e raz&#245;es das chances (hazard ratios) de reinterna&#231;&#227;o estimadas pelo modelo de regress&#227;o log&#237;stica, com intervalo de 95% de confian&#231;a, por perfil hemodin&#226;mico (perfil de refer&#234;ncia: quente-seco)</title>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup width="20%">
              <col/>
              <col/>
              <col/>
              <col/>
              <col/>
            </colgroup>
            <thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
              <tr style="background-color:#78B2CB;">
                <th align="left" rowspan="2" valign="middle">Perfil Hemodin&#226;mico</th>
                <th align="center" colspan="4" style="border-bottom: thin solid; border-color: #000000" valign="middle">Hazard ratio para &#243;bito hospitalar- HR (IC 95%)</th>
              </tr>
              <tr style="background-color:#78B2CB;">
                <th align="center" valign="middle">Modelo n&#227;o ajustado</th>
                <th align="center" valign="middle">Modelo ajustado (sexo, idade)</th>
                <th align="center" valign="middle">Modelo ajustado (sexo, idade e comorbidades<xref ref-type="table-fn" rid="TFN5">&#8224;</xref>)</th>
                <th align="center" valign="middle">Modelo ajustado (anteriores e FEVE<xref ref-type="table-fn" rid="TFN6">&#8225;</xref>)</th>
              </tr>
            </thead>
            <tbody style="border-bottom: thin solid; border-color: #000000">
              <tr>
                <td align="left" valign="top">Quente e &#250;mido</td>
                <td align="center" valign="top">1,35 (IC 0,78-2,35)</td>
                <td align="center" valign="top">1,31 (0,75-2,27)</td>
                <td align="center" valign="top">1,33 (0,76-2,31)</td>
                <td align="center" valign="top">1,33 (0,76-2,33)</td>
              </tr>
              <tr>
                <td align="left" valign="top">Frio e &#250;mido<xref ref-type="table-fn" rid="TFN4">*</xref> </td>
                <td align="center" valign="top">2,21 (1,24-3,95)</td>
                <td align="center" valign="top">2,15 (1,20-3,85)</td>
                <td align="center" valign="top">2,18 (1,21-3,93)</td>
                <td align="center" valign="top">2,20 (1,20 &#8211; 4,04)</td>
              </tr>
              <tr>
                <td align="left" style="border-bottom: thin solid; border-color: #000000" valign="top">Frio e seco<xref ref-type="table-fn" rid="TFN4">*</xref> </td>
                <td align="center" style="border-bottom: thin solid; border-color: #000000" valign="top">2,5 (1,08- 5,77)</td>
                <td align="center" style="border-bottom: thin solid; border-color: #000000" valign="top">2,53 (1,09- 5,87)</td>
                <td align="center" style="border-bottom: thin solid; border-color: #000000" valign="top">2,37 (1,02- 5,52)</td>
                <td align="center" style="border-bottom: thin solid; border-color: #000000" valign="top">2,39 (1,02- 5,57)</td>
              </tr>
              <tr style="background-color:#78B2CB;">
                <td align="left" rowspan="2" valign="middle">
                  <bold>Perfil Hemodin&#226;mico</bold>
                </td>
                <td align="center" colspan="4" style="border-bottom: thin solid; border-color: #000000" valign="middle">
                  <bold>Hazard ratio para &#243;bito no seguimento de 6 meses- HR (IC 95%)</bold>
                </td>
              </tr>
              <tr style="background-color:#78B2CB;">
                <td align="center" valign="middle">
                  <bold>Modelo n&#227;o ajustado</bold>
                </td>
                <td align="center" valign="middle">
                  <bold>Modelo ajustado (sexo, idade)</bold>
                </td>
                <td align="center" valign="middle">
                  <bold>Modelo ajustado (sexo, idade e comorbidades</bold>
                  <xref ref-type="table-fn" rid="TFN5">&#8224;</xref>
                  <bold>)</bold>
                </td>
                <td align="center" valign="middle">
                  <bold>Modelo ajustado (anteriores e FEVE</bold>
                  <xref ref-type="table-fn" rid="TFN6">&#8225;</xref>
                  <bold>)</bold>
                </td>
              </tr>
              <tr>
                <td align="left" valign="top">Quente e &#250;mido</td>
                <td align="center" valign="top">1,33 (0,93-1,92)</td>
                <td align="center" valign="top">1,26 (0,87-1,82)</td>
                <td align="center" valign="top">1,20 (0,83-1,74)</td>
                <td align="center" valign="top">1,18 (0,82-1,72)</td>
              </tr>
              <tr>
                <td align="left" valign="top">Frio e &#250;mido<xref ref-type="table-fn" rid="TFN4">*</xref> </td>
                <td align="center" valign="top">2,34 (1,57- 3,5)</td>
                <td align="center" valign="top">2,24 (1,5- 3,34)</td>
                <td align="center" valign="top">2,02 (1,34- 3,03)</td>
                <td align="center" valign="top">1,96 (1,3- 2,97)</td>
              </tr>
              <tr>
                <td align="left" style="border-bottom: thin solid; border-color: #000000" valign="top">Frio e seco</td>
                <td align="center" style="border-bottom: thin solid; border-color: #000000" valign="top">1,66 (0,89-3,11)</td>
                <td align="center" style="border-bottom: thin solid; border-color: #000000" valign="top">1,54 (0,82-2,89)</td>
                <td align="center" style="border-bottom: thin solid; border-color: #000000" valign="top">1,36 (0,73-2,57)</td>
                <td align="center" style="border-bottom: thin solid; border-color: #000000" valign="top">1,34 (0,71-2,53)</td>
              </tr>
              <tr style="background-color:#78B2CB;">
                <td align="left" rowspan="2" valign="middle">
                  <bold>Perfil Hemodin&#226;mico</bold>
                </td>
                <td align="center" colspan="4" style="border-bottom: thin solid; border-color: #000000" valign="middle">
                  <bold>Odds Ratio para reinterna&#231;&#227;o em 6 meses- OR (IC 95%)</bold>
                </td>
              </tr>
              <tr style="background-color:#78B2CB;">
                <td align="center" valign="middle">
                  <bold>Modelo n&#227;o ajustado</bold>
                </td>
                <td align="center" valign="middle">
                  <bold>Modelo ajustado (sexo, idade)</bold>
                </td>
                <td align="center" valign="middle">
                  <bold>Modelo ajustado (sexo, idade e comorbidades</bold>
                  <xref ref-type="table-fn" rid="TFN5">&#8224;</xref>
                  <bold>)</bold>
                </td>
                <td align="center" valign="middle">
                  <bold>Modelo ajustado (anteriores e FEVE</bold>
                  <xref ref-type="table-fn" rid="TFN6">&#8225;</xref>
                  <bold>)</bold>
                </td>
              </tr>
              <tr>
                <td align="left" valign="top">Quente e &#250;mido<xref ref-type="table-fn" rid="TFN4">*</xref> </td>
                <td align="center" valign="top">2,51 (1,54-4,33)</td>
                <td align="center" valign="top">2,55 (1,56-4,42)</td>
                <td align="center" valign="top">2,38 (1,45-4,14)</td>
                <td align="center" valign="top">2,39 (1,41-4,05)</td>
              </tr>
              <tr>
                <td align="left" valign="top">Frio e &#250;mido<xref ref-type="table-fn" rid="TFN4">*</xref> </td>
                <td align="center" valign="top">2,75 (1,54-5,10)</td>
                <td align="center" valign="top">2,81 (1,57-5,22)</td>
                <td align="center" valign="top">2,57 (1,42-4,8)</td>
                <td align="center" valign="top">2,59 (1,40-4,79)</td>
              </tr>
              <tr>
                <td align="left" valign="top">Frio e seco</td>
                <td align="center" valign="top">1,35 (0,46-3,49)</td>
                <td align="center" valign="top">1,39 (0,47-3,61)</td>
                <td align="center" valign="top">1,27 (0,43-3,34)</td>
                <td align="center" valign="top">1,28 (0,47-3,51)</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="TFN4">
              <label>*</label>
              <p>p valor &lt; 0,05 para diferen&#231;a entre os perfis hemodin&#226;micos.</p>
            </fn>
            <fn id="TFN5">
              <label>&#8224;</label>
              <p>Hipertens&#227;o arterial, doen&#231;a pulmonar obstrutiva cr&#244;nica, doen&#231;a de Chagas, doen&#231;a coronariana, diabetes, fibrila&#231;&#227;o atrial/flutter atrial);</p>
            </fn>
            <fn id="TFN6">
              <label>&#8225;</label>
              <p>Modelos ajustados com m&#233;todo de imputa&#231;&#227;o m&#250;ltipla para os valores faltantes da vari&#225;vel FEVE (fra&#231;&#227;o de eje&#231;&#227;o do ventr&#237;culo esquerdo).</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>Al&#233;m disso, comparado ao perfil de refer&#234;ncia (quente-seco), os pacientes admitidos em perfil quente-&#250;mido tiveram maior chance de reinterna&#231;&#227;o em seis meses (OR= 2,39; IC 95% 1,41-4,05), assim como aqueles de perfil frio-&#250;mido (OR= 2,59, IC 95% 1,40-4,79) (<xref ref-type="table" rid="t3">Tabela 3</xref>).</p>
        <p>Avaliou-se tamb&#233;m separadamente a perfus&#227;o (perfis frios x perfis quentes) e a congest&#227;o (perfis &#250;midos x perfis secos) pela an&#225;lise multivariada. Para o desfecho prim&#225;rio de &#243;bito na interna&#231;&#227;o, os perfis frios aumentaram o risco quando comparados aos perfis quentes (HR= 1,72, IC 95% 1,27-2,31). Os perfis &#250;midos, por sua vez, n&#227;o se associaram ao aumento de risco de &#243;bito na interna&#231;&#227;o (HR= 1,17, IC 95% 0,76-1,80). O mesmo resultado &#233; observado na an&#225;lise do per&#237;odo total (mortalidade hospitalar e em 6 meses de seguimento), com risco aumentado de morte para os perfis frios em rela&#231;&#227;o aos perfis quentes (HR= 1,61; IC 95% 1,29-2,02) e sem aumento de risco para os perfis &#250;midos em rela&#231;&#227;o aos secos (HR= 1,27; IC 95% 0,93-1,73).</p>
        <p>Quanto &#224; chance de reinterna&#231;&#227;o no per&#237;odo em seis meses, observamos que os pacientes admitidos com perfis &#250;midos apresentaram risco aumentado de reinterna&#231;&#227;o (OR= 2,30, IC 95% 1,45-3,65), comparado ao grupo com perfis secos. J&#225; os perfis frios, comparados aos perfis quentes, n&#227;o aumentaram o risco de reinterna&#231;&#227;o com signific&#226;ncia estat&#237;stica (OR= 1,10; IC 95% 0,78-1,56).</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discuss&#227;o</title>
      <p>Os resultados do nosso estudo trazem marcadores progn&#243;sticos para os pacientes internados por IC aguda no Brasil. As principais caracter&#237;sticas desses pacientes foram renda familiar baixa, em sua maioria idosos e do sexo masculino, com m&#250;ltiplas comorbidades, fra&#231;&#227;o de eje&#231;&#227;o reduzida e IC j&#225; conhecida e sintom&#225;tica. A distribui&#231;&#227;o da etiologia da IC foi semelhante &#224; descrita na literatura,<sup><xref ref-type="bibr" rid="B3">3</xref></sup> mas vale destacar a alta preval&#234;ncia de doen&#231;a de Chagas em nosso meio, que correspondeu a quase 10% da amostra. A maior parte dos pacientes foi admitida no servi&#231;o de emerg&#234;ncia com perfil quente e &#250;mido. Foram encontradas altas taxas de mortalidade e reinterna&#231;&#227;o hospitalar, com associa&#231;&#227;o significativa ao perfil hemodin&#226;mico de admiss&#227;o.</p>
      <p>O tempo de perman&#234;ncia hospitalar foi 10 dias maior que de coortes internacionais, onde o tempo m&#233;dio &#233; de aproximadamente sete dias.<sup><xref ref-type="bibr" rid="B3">3</xref></sup> Esse dado &#233; preocupante j&#225; que o estudo foi realizado em centros de refer&#234;ncia da sa&#250;de p&#250;blica brasileira e demonstra a dificuldade de otimiza&#231;&#227;o das terapias em tempo h&#225;bil. Isso tamb&#233;m pode representar maior gravidade desses pacientes &#224; admiss&#227;o por dificuldade de acesso &#224; proped&#234;utica e tratamento adequado, considerando o contexto social da popula&#231;&#227;o do estudo.</p>
      <p>Em rela&#231;&#227;o &#224; taxa de mortalidade intra-hospitalar, o estudo apresentou resultados semelhantes ao &#250;ltimo registro brasileiro (11,1% x 12,6%).<sup><xref ref-type="bibr" rid="B2">2</xref></sup> As taxas tamb&#233;m s&#227;o semelhantes aos dados existentes da mortalidade na Am&#233;rica Latina (11,1% x 11,7%).<sup><xref ref-type="bibr" rid="B14">14</xref></sup> Sabemos que os dados variam entre os centros participantes pelo perfil de pacientes admitidos em cada local. Dados recentemente publicados do Hospital das Cl&#237;nicas da UFMG, em Belo Horizonte, exibem maior mortalidade hospitalar (17,9%),<sup><xref ref-type="bibr" rid="B15">15</xref></sup> por&#233;m a etiologia predominante da IC foi Doen&#231;a de Chagas (25,8%) e 18,3% dos pacientes foram encaminhados para transplante card&#237;aco na mesma interna&#231;&#227;o, confirmando a maior gravidade dessa amostra.<sup><xref ref-type="bibr" rid="B16">16</xref></sup></p>
      <p>Dados da coorte do presente estudo revelam maior mortalidade hospitalar (11,1%) ao se comparar os de coortes europeias (5,5%)<sup><xref ref-type="bibr" rid="B3">3</xref></sup> e americanas (4,0%).<sup><xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B17">17</xref></sup> Ao se estratificar essa mortalidade pelo perfil hemodin&#226;mico de admiss&#227;o, encontramos taxas maiores para os perfis frios, que representam os pacientes hipotensos e mais graves, com comprometimento multiorg&#226;nico pela IC. Em nosso modelo ajustado, encontramos um aumento de risco de &#243;bito intra-hospitalar com <italic>hazard ratio</italic> de 2,20 (IC 95% 1,20 &#8211; 4,04) para o perfil hemodin&#226;mico frio-&#250;mido. Em um registro europeu semelhante, esse perfil associou-se ao risco de &#243;bito intra-hospitalar com <italic>hazard-ratio</italic> de 3,47 (IC 95 % 2,31-5,22).<sup><xref ref-type="bibr" rid="B5">5</xref></sup> Diante disso, o manejo dos pacientes desse grupo deve ser imediato e eficaz, a fim de tentar reverter a evolu&#231;&#227;o natural dessa apresenta&#231;&#227;o, com alta chance de &#243;bito. Times de reposta r&#225;pida em choque cardiog&#234;nico e protocolos institucionais bem elaborados podem contribuir para melhoria dos resultados.<sup><xref ref-type="bibr" rid="B18">18</xref></sup></p>
      <p>Ao se analisar a mortalidade geral do estudo, agrupando a mortalidade hospitalar e no seguimento de seis meses, tamb&#233;m h&#225; diferen&#231;a estat&#237;stica entre os perfis, com maior taxa de mortalidade para o perfil frio-&#250;mido (32%). Esse perfil apresentou maior risco de morte no seguimento, com <italic>hazard-ratio</italic> de 1,96 (IC 95% 1,3-2,97). Dados europeus corroboram esses achados, com taxas de mortalidade geral em um ano de 26,7% ap&#243;s interna&#231;&#227;o hospitalar por IC aguda, sendo de 54% nos pacientes admitidos em choque cardiog&#234;nico.<sup><xref ref-type="bibr" rid="B3">3</xref></sup></p>
      <p>Outro achado do estudo foi a maior chance de reinterna&#231;&#227;o dos pacientes com perfis &#250;midos (OR = 2,30; IC 95% 1,45-3,65), que apresentaram sintomas congestivos recorrentes no seguimento. &#201; descrito na literatura que os perfis mais congestos t&#234;m maior taxa de reinterna&#231;&#227;o em um ano, sendo de 32,2% para perfil frio-&#250;mido, 26,9% para perfil quente-&#250;mido e somente 16,4% para perfil quente-seco (p&lt;0,001)<sup><xref ref-type="bibr" rid="B3">3</xref></sup>. Diferentemente dos perfis quentes, os perfis frios isoladamente n&#227;o se associaram ao aumento de reinterna&#231;&#245;es (OR= 1,10, IC 95% 0,78-1,56), o que pode estar associado &#224; maior mortalidade intra-hospitalar nesses perfis.</p>
      <p>H&#225; um per&#237;odo de vulnerabilidade nos 30 dias ap&#243;s a alta, em que o acompanhamento &#233; importante para reavaliar sintomas congestivos ou outras complica&#231;&#245;es, a fim de prevenir reinterna&#231;&#245;es. Estrat&#233;gias de otimiza&#231;&#227;o e monitoriza&#231;&#227;o do tratamento devem ser tra&#231;adas antes da alta e para o seguimento ambulatorial. Essas medidas envolvem desde avalia&#231;&#227;o multidisciplinar: orienta&#231;&#245;es diet&#233;ticas, ader&#234;ncia medicamentosa e programas de reabilita&#231;&#227;o card&#237;aca, at&#233; avalia&#231;&#227;o m&#233;dica peri&#243;dica quanto ao ajuste e toler&#226;ncia a medica&#231;&#245;es, monitoriza&#231;&#227;o de biomarcadores e sintomas congestivos.<sup><xref ref-type="bibr" rid="B19">19</xref></sup> Como exemplo, o estudo multic&#234;ntrico randomizado STRONG-HF<sup><xref ref-type="bibr" rid="B20">20</xref></sup> comparou uma estrat&#233;gia mais intensiva de seguimento ambulatorial ap&#243;s interna&#231;&#227;o por IC aguda, com titula&#231;&#227;o das medica&#231;&#245;es modificadoras de doen&#231;a (betabloqueadores, bloqueadores do sistema renina-angiotensina e antagonistas dos receptores mineralocorticoides) at&#233; doses-alvo em duas semanas ap&#243;s a alta, em vez do manejo habitual, e demonstrou redu&#231;&#227;o de reinterna&#231;&#227;o ou &#243;bito em 6 meses de 23% para 15% (p = 0,002).</p>
      <p>O presente estudo apresenta limita&#231;&#245;es por se tratar de uma coorte, estudo de n&#227;o interven&#231;&#227;o, em que as associa&#231;&#245;es entre perfil hemodin&#226;mico e desfechos podem conter vieses. As perdas por falhas de registro ou seguimento foram altas, mas todas consideradas nas an&#225;lises estat&#237;sticas. A informa&#231;&#227;o sobre a reinterna&#231;&#227;o em seis meses foi coletada por liga&#231;&#227;o telef&#244;nica, de forma categ&#243;rica (presente ou ausente) e isso limitou a melhor caracteriza&#231;&#227;o desse desfecho. Al&#233;m disso, a classifica&#231;&#227;o do perfil hemodin&#226;mico foi realizada pelo julgamento cl&#237;nico do m&#233;dico emergencista, o que traduz subjetividade, mas se aproxima mais da realidade. O estudo foi realizado em hospitais terci&#225;rios, a maioria tamb&#233;m universit&#225;rios, que s&#227;o centros de refer&#234;ncia regionais. Se as Unidades de Pronto Atendimento (servi&#231;o m&#233;dico de urg&#234;ncia pr&#233;-hospitalar no sistema de sa&#250;de brasileiro) e hospitais de baixa complexidade fossem avaliados no estudo, nossos resultados poderiam ser diferentes.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclus&#227;o</title>
      <p>A IC aguda no Brasil apresenta alta morbimortalidade, que se relaciona com o perfil hemodin&#226;mico de admiss&#227;o hospitalar. Os pacientes admitidos em perfil frio (mal perfundidos) tiveram um risco de &#243;bito aumentado em 72% na interna&#231;&#227;o e em 61% no seguimento de seis meses. Pacientes que se apresentavam congestos (perfil &#250;mido) t&#234;m 2,3 mais chances de reinterna&#231;&#227;o em seis meses.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="financial-disclosure">
        <p>
          <bold>Fontes de financiamento</bold>
        </p>
        <p>O presente estudo n&#227;o teve fontes de financiamento externas.</p>
      </fn>
      <fn fn-type="other" id="fn2">
        <p>
          <bold>Vincula&#231;&#227;o acad&#234;mica</bold>
        </p>
        <p>Este artigo &#233; parte de disserta&#231;&#227;o de mestrado de Andr&#233; Silva Rodrigues pela Universidade Federal de Minas Gerais.</p>
      </fn>
      <fn fn-type="other" id="fn3">
        <p>
          <bold>Aprova&#231;&#227;o &#233;tica e consentimento informado</bold>
        </p>
        <p>Este estudo foi aprovado pelo Comit&#234; de &#201;tica da Universidade Federal de Minas Gerais sob o n&#250;mero de protocolo 1.487.029. Todos os procedimentos envolvidos nesse estudo est&#227;o de acordo com a Declara&#231;&#227;o de Helsinki de 1975, atualizada em 2013. O consentimento informado foi obtido de todos os participantes inclu&#237;dos no estudo.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>Refer&#234;ncias</title>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oliveira</surname>
              <given-names>GMM</given-names>
            </name>
            <name>
              <surname>Brant</surname>
              <given-names>LCC</given-names>
            </name>
            <name>
              <surname>Polanczyk</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Malta</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Biolo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nascimento</surname>
              <given-names>BR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cardiovascular Statistics - Brazil 2021</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2022</year>
          <volume>118</volume>
          <issue>1</issue>
          <fpage>115</fpage>
          <lpage>373</lpage>
          <pub-id pub-id-type="doi">10.36660/abc.20211012</pub-id>
        </element-citation>
        <mixed-citation>1 Oliveira GMM, Brant LCC, Polanczyk CA, Malta DC, Biolo A, Nascimento BR, et al. Cardiovascular Statistics - Brazil 2021. Arq Bras Cardiol. 2022;118(1):115-373. doi: 10.36660/abc.20211012.</mixed-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Albuquerque</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>JD</given-names>
              <suffix>Neto</suffix>
            </name>
            <name>
              <surname>Bacal</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rohde</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Bernardez-Pereira</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Berwanger</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>I Brazilian Registry of Heart Failure - Clinical Aspects, Care Quality and Hospitalization Outcomes</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2015</year>
          <volume>104</volume>
          <issue>6</issue>
          <fpage>433</fpage>
          <lpage>442</lpage>
          <pub-id pub-id-type="doi">10.5935/abc.20150031</pub-id>
        </element-citation>
        <mixed-citation>2 Albuquerque DC, Souza JD Neto, Bacal F, Rohde LE, Bernardez-Pereira S, Berwanger O, et al. I Brazilian Registry of Heart Failure - Clinical Aspects, Care Quality and Hospitalization Outcomes. Arq Bras Cardiol. 2015;104(6):433-42. doi: 10.5935/abc.20150031.</mixed-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chioncel</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Mebazaa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Harjola</surname>
              <given-names>VP</given-names>
            </name>
            <name>
              <surname>Coats</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Piepoli</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Crespo-Leiro</surname>
              <given-names>MG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical Phenotypes and Outcome of Patients Hospitalized for Acute Heart Failure: The ESC Heart Failure Long-Term Registry</article-title>
          <source>Eur J Heart Fail</source>
          <year>2017</year>
          <volume>19</volume>
          <issue>10</issue>
          <fpage>1242</fpage>
          <lpage>1254</lpage>
          <pub-id pub-id-type="doi">10.1002/ejhf.890</pub-id>
        </element-citation>
        <mixed-citation>3 Chioncel O, Mebazaa A, Harjola VP, Coats AJ, Piepoli MF, Crespo-Leiro MG, et al. Clinical Phenotypes and Outcome of Patients Hospitalized for Acute Heart Failure: The ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2017;19(10):1242-54. doi: 10.1002/ejhf.890.</mixed-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adams</surname>
              <given-names>KF</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Fonarow</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Emerman</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>LeJemtel</surname>
              <given-names>TH</given-names>
            </name>
            <name>
              <surname>Costanzo</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Abraham</surname>
              <given-names>WT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Characteristics and Outcomes of Patients Hospitalized for Heart Failure in the United States: Rationale, Design, and Preliminary Observations from the first 100,000 Cases in the Acute Decompensated Heart Failure National Registry (ADHERE)</article-title>
          <source>Am Heart J</source>
          <year>2005</year>
          <volume>149</volume>
          <issue>2</issue>
          <fpage>209</fpage>
          <lpage>216</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ahj.2004.08.005</pub-id>
        </element-citation>
        <mixed-citation>4 Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, et al. Characteristics and Outcomes of Patients Hospitalized for Heart Failure in the United States: Rationale, Design, and Preliminary Observations from the first 100,000 Cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149(2):209-16. doi: 10.1016/j.ahj.2004.08.005.</mixed-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Javaloyes</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Mir&#243;</surname>
              <given-names>&#210;</given-names>
            </name>
            <name>
              <surname>Gil</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Mart&#237;n-S&#225;nchez</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Jacob</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Herrero</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical Phenotypes of Acute Heart Failure Based on Signs and Symptoms of Perfusion and Congestion at Emergency Department Presentation and Their Relationship with Patient Management and Outcomes</article-title>
          <source>Eur J Heart Fail</source>
          <year>2019</year>
          <volume>21</volume>
          <issue>11</issue>
          <fpage>1353</fpage>
          <lpage>1365</lpage>
          <pub-id pub-id-type="doi">10.1002/ejhf.1502</pub-id>
        </element-citation>
        <mixed-citation>5 Javaloyes P, Mir&#243; &#210;, Gil V, Mart&#237;n-S&#225;nchez FJ, Jacob J, Herrero P, et al. Clinical Phenotypes of Acute Heart Failure Based on Signs and Symptoms of Perfusion and Congestion at Emergency Department Presentation and Their Relationship with Patient Management and Outcomes. Eur J Heart Fail. 2019;21(11):1353-65. doi: 10.1002/ejhf.1502.</mixed-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Remes</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Miettinen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Reunanen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Py&#246;r&#228;l&#228;</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Validity of Clinical Diagnosis of Heart Failure in Primary Health Care</article-title>
          <source>Eur Heart J</source>
          <year>1991</year>
          <volume>12</volume>
          <issue>3</issue>
          <fpage>315</fpage>
          <lpage>321</lpage>
          <pub-id pub-id-type="doi">10.1093/oxfordjournals.eurheartj.a059896</pub-id>
        </element-citation>
        <mixed-citation>6 Remes J, Miettinen H, Reunanen A, Py&#246;r&#228;l&#228; K. Validity of Clinical Diagnosis of Heart Failure in Primary Health Care. Eur Heart J. 1991;12(3):315-21. doi: 10.1093/oxfordjournals.eurheartj.a059896.</mixed-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Forrester</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Diamond</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Chatterjee</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Swan</surname>
              <given-names>HJ</given-names>
            </name>
          </person-group>
          <article-title>Medical Therapy of Acute Myocardial Infarction by Application of Hemodynamic Subsets (First of Two Parts)</article-title>
          <source>N Engl J Med</source>
          <year>1976</year>
          <volume>295</volume>
          <issue>24</issue>
          <fpage>1356</fpage>
          <lpage>1362</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJM197612092952406</pub-id>
        </element-citation>
        <mixed-citation>7 Forrester JS, Diamond G, Chatterjee K, Swan HJ. Medical Therapy of Acute Myocardial Infarction by Application of Hemodynamic Subsets (First of Two Parts). N Engl J Med. 1976;295(24):1356-62. doi: 10.1056/NEJM197612092952406.</mixed-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stevenson</surname>
              <given-names>LW</given-names>
            </name>
            <name>
              <surname>Perloff</surname>
              <given-names>JK</given-names>
            </name>
          </person-group>
          <article-title>The Limited Reliability of Physical Signs for Estimating Hemodynamics in Chronic Heart Failure</article-title>
          <source>JAMA</source>
          <year>1989</year>
          <volume>261</volume>
          <issue>6</issue>
          <fpage>884</fpage>
          <lpage>888</lpage>
        </element-citation>
        <mixed-citation>8 Stevenson LW, Perloff JK. The Limited Reliability of Physical Signs for Estimating Hemodynamics in Chronic Heart Failure. JAMA. 1989;261(6):884-8.</mixed-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nohria</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lewis</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Stevenson</surname>
              <given-names>LW</given-names>
            </name>
          </person-group>
          <article-title>Medical Management of Advanced Heart Failure</article-title>
          <source>JAMA</source>
          <year>2002</year>
          <volume>287</volume>
          <issue>5</issue>
          <fpage>628</fpage>
          <lpage>640</lpage>
          <pub-id pub-id-type="doi">10.1001/jama.287.5.628</pub-id>
        </element-citation>
        <mixed-citation>9 Nohria A, Lewis E, Stevenson LW. Medical Management of Advanced Heart Failure. JAMA. 2002;287(5):628-40. doi: 10.1001/jama.287.5.628.</mixed-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taniguchi</surname>
              <given-names>FP</given-names>
            </name>
            <name>
              <surname>Bernardez-Pereira</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>ALP</given-names>
            </name>
            <name>
              <surname>Morgan</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Curtis</surname>
              <given-names>AB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Implementation of a Best Practice in Cardiology (BPC) Program Adapted from Get With The Guidelines&#174;in Brazilian Public Hospitals: Study Design and Rationale</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2020</year>
          <volume>115</volume>
          <issue>1</issue>
          <fpage>92</fpage>
          <lpage>99</lpage>
          <pub-id pub-id-type="doi">10.36660/abc.20190393</pub-id>
        </element-citation>
        <mixed-citation>10 Taniguchi FP, Bernardez-Pereira S, Silva SA, Ribeiro ALP, Morgan L, Curtis AB, et al. Implementation of a Best Practice in Cardiology (BPC) Program Adapted from Get With The Guidelines&#174;in Brazilian Public Hospitals: Study Design and Rationale. Arq Bras Cardiol. 2020;115(1):92-9. doi: 10.36660/abc.20190393.</mixed-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>Hospital do Cora&#231;&#227;o de S&#227;o Paulo</collab>
          </person-group>
          <source>Ades&#227;o &#224;s Diretrizes Assistenciais de Insufici&#234;ncia Card&#237;aca, Fibrila&#231;&#227;o Atrial e S&#237;ndrome Coronariana Aguda: um Programa de Boas Pr&#225;ticas Cl&#237;nicas em Cardiologia</source>
          <publisher-loc>S&#227;o Paulo</publisher-loc>
          <publisher-name>Sociedade Brasileira de Cardiologia</publisher-name>
          <year>2018</year>
        </element-citation>
        <mixed-citation>11 Hospital do Cora&#231;&#227;o de S&#227;o Paulo. Ades&#227;o &#224;s Diretrizes Assistenciais de Insufici&#234;ncia Card&#237;aca, Fibrila&#231;&#227;o Atrial e S&#237;ndrome Coronariana Aguda: um Programa de Boas Pr&#225;ticas Cl&#237;nicas em Cardiologia. S&#227;o Paulo: Sociedade Brasileira de Cardiologia; 2018.</mixed-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taniguchi</surname>
              <given-names>FP</given-names>
            </name>
            <name>
              <surname>Bernardez-Pereira</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>ALP</given-names>
            </name>
            <name>
              <surname>Morgan</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Curtis</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Taubert</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A Nationwide Initiative to Improve Cardiology Quality: The Best Practice in Cardiology Program in Brazil</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2023</year>
          <volume>120</volume>
          <issue>10</issue>
          <elocation-id>e20230375</elocation-id>
          <pub-id pub-id-type="doi">10.36660/abc.20230375</pub-id>
        </element-citation>
        <mixed-citation>12 Taniguchi FP, Bernardez-Pereira S, Ribeiro ALP, Morgan L, Curtis AB, Taubert K, et al. A Nationwide Initiative to Improve Cardiology Quality: The Best Practice in Cardiology Program in Brazil. Arq Bras Cardiol. 2023;120(10):e20230375. doi: 10.36660/abc.20230375.</mixed-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Buuren</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Groothuis-Oudshoorn</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Mice: Multivariate Imputation by Chained Equations in R</article-title>
          <source>J Stat Soft</source>
          <year>2011</year>
          <volume>45</volume>
          <issue>3</issue>
          <fpage>1</fpage>
          <lpage>67</lpage>
          <pub-id pub-id-type="doi">10.18637/jss.v045.i03</pub-id>
        </element-citation>
        <mixed-citation>13 van Buuren S, Groothuis-Oudshoorn K. Mice: Multivariate Imputation by Chained Equations in R. J Stat Soft. 2011;45(3):1-67. doi: 10.18637/jss.v045.i03.</mixed-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ciapponi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Alcaraz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Calder&#243;n</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Matta</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Chaparro</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Soto</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Burden of Heart Failure in Latin America: A Systematic Review and Meta-analysis</article-title>
          <source>Rev Esp Cardiol</source>
          <year>2016</year>
          <volume>69</volume>
          <issue>11</issue>
          <fpage>1051</fpage>
          <lpage>1060</lpage>
          <pub-id pub-id-type="doi">10.1016/j.rec.2016.04.054</pub-id>
        </element-citation>
        <mixed-citation>14 Ciapponi A, Alcaraz A, Calder&#243;n M, Matta MG, Chaparro M, Soto N, et al. Burden of Heart Failure in Latin America: A Systematic Review and Meta-analysis. Rev Esp Cardiol. 2016;69(11):1051-60. doi: 10.1016/j.rec.2016.04.054.</mixed-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Passaglia</surname>
              <given-names>LG</given-names>
            </name>
            <name>
              <surname>Cerqueira</surname>
              <given-names>MLR</given-names>
            </name>
            <name>
              <surname>Pires</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Chagas</surname>
              <given-names>LV</given-names>
            </name>
            <name>
              <surname>&#201;rika</surname>
              <given-names>CTC</given-names>
            </name>
            <name>
              <surname>Rodrigues</surname>
              <given-names>ENO</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cardiovascular Statistics from the Good Practices in Cardiology Program - Data from a Brazilian Tertiary Public Hospital</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2023</year>
          <volume>120</volume>
          <issue>2</issue>
          <elocation-id>e20220247</elocation-id>
          <pub-id pub-id-type="doi">10.36660/abc.20220247</pub-id>
        </element-citation>
        <mixed-citation>15 Passaglia LG, Cerqueira MLR, Pires MM, Chagas LV, &#201;rika CTC, Rodrigues ENO, et al. Cardiovascular Statistics from the Good Practices in Cardiology Program - Data from a Brazilian Tertiary Public Hospital. Arq Bras Cardiol. 2023;120(2):e20220247. doi: 10.36660/abc.20220247.</mixed-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nunes</surname>
              <given-names>MCP</given-names>
            </name>
            <name>
              <surname>Barbosa</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>ALP</given-names>
            </name>
            <name>
              <surname>Fenelon</surname>
              <given-names>LMA</given-names>
            </name>
            <name>
              <surname>Rocha</surname>
              <given-names>MO</given-names>
            </name>
          </person-group>
          <article-title>Predictors of Mortality in Patients with Dilated Cardiomyopathy: Relevance of Chagas Disease as an Etiological Factor</article-title>
          <source>Rev Esp Cardiol</source>
          <year>2010</year>
          <volume>63</volume>
          <issue>7</issue>
          <fpage>788</fpage>
          <lpage>797</lpage>
          <pub-id pub-id-type="doi">10.1016/s1885-5857(10)70163-8</pub-id>
        </element-citation>
        <mixed-citation>16 Nunes MCP, Barbosa MM, Ribeiro ALP, Fenelon LMA, Rocha MO. Predictors of Mortality in Patients with Dilated Cardiomyopathy: Relevance of Chagas Disease as an Etiological Factor. Rev Esp Cardiol. 2010;63(7):788-97. doi: 10.1016/s1885-5857(10)70163-8.</mixed-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abraham</surname>
              <given-names>WT</given-names>
            </name>
            <name>
              <surname>Fonarow</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Albert</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Stough</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>Gheorghiade</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Greenberg</surname>
              <given-names>BH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Predictors of In-hospital Mortality in Patients Hospitalized for Heart Failure: Insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2008</year>
          <volume>52</volume>
          <issue>5</issue>
          <fpage>347</fpage>
          <lpage>356</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jacc.2008.04.028</pub-id>
        </element-citation>
        <mixed-citation>17 Abraham WT, Fonarow GC, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, et al. Predictors of In-hospital Mortality in Patients Hospitalized for Heart Failure: Insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol. 2008;52(5):347-56. doi: 10.1016/j.jacc.2008.04.028.</mixed-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McDonagh</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Metra</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Adamo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gardner</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Baumbach</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>B&#246;hm</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure</article-title>
          <source>Eur Heart J</source>
          <year>2021</year>
          <volume>42</volume>
          <issue>36</issue>
          <fpage>3599</fpage>
          <lpage>3726</lpage>
          <pub-id pub-id-type="doi">10.1093/eurheartj/ehab368</pub-id>
        </element-citation>
        <mixed-citation>18 McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B&#246;hm M, et al. 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. Eur Heart J. 2021;42(36):3599-726. doi: 10.1093/eurheartj/ehab368.</mixed-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Palazzuoli</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Evangelista</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Ruocco</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lombardi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Giovannini</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Nuti</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Early Readmission for Heart Failure: An Avoidable or Ineluctable Debacle?</article-title>
          <source>Int J Cardiol</source>
          <year>2019</year>
          <volume>277</volume>
          <fpage>186</fpage>
          <lpage>195</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ijcard.2018.09.039</pub-id>
        </element-citation>
        <mixed-citation>19 Palazzuoli A, Evangelista I, Ruocco G, Lombardi C, Giovannini V, Nuti R, et al. Early Readmission for Heart Failure: An Avoidable or Ineluctable Debacle? Int J Cardiol. 2019;277:186-95. doi: 10.1016/j.ijcard.2018.09.039.</mixed-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mebazaa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Davison</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Chioncel</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Cohen-Solal</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Diaz</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Filippatos</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Safety, Tolerability and Efficacy of Up-titration of Guideline-directed Medical Therapies for Acute Heart Failure (STRONG-HF): A Multinational, Open-label, Randomised, Trial</article-title>
          <source>Lancet</source>
          <year>2022</year>
          <volume>400</volume>
          <issue>10367</issue>
          <fpage>1938</fpage>
          <lpage>1952</lpage>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(22)02076-1</pub-id>
        </element-citation>
        <mixed-citation>20 Mebazaa A, Davison B, Chioncel O, Cohen-Solal A, Diaz R, Filippatos G, et al. Safety, Tolerability and Efficacy of Up-titration of Guideline-directed Medical Therapies for Acute Heart Failure (STRONG-HF): A Multinational, Open-label, Randomised, Trial. Lancet. 2022;400(10367):1938-52. doi: 10.1016/S0140-6736(22)02076-1.</mixed-citation>
      </ref>
    </ref-list>
    <app-group>
      <app id="app1">
        <title>*Material suplementar</title>
        <p>Para informa&#231;&#227;o adicional, por favor, clique <ext-link ext-link-type="uri" xlink:href="https://abccardiol.org/supplementary-material/2024/12105/2023-0699_suplementar_portugues.pdf">aqui</ext-link>.</p>
      </app>
    </app-group>
  </back>
  <sub-article article-type="translation" id="S1" xml:lang="en">
    <front-stub>
      <article-id pub-id-type="doi">10.36660/abc.20230699i</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Association between Hemodynamic Profile at Hospital Admission and Mortality in Acute Heart Failure Patients Included in the Best Practice in Cardiology Program in Brazil</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0009-0004-8073-9768</contrib-id>
          <name>
            <surname>Rodrigues</surname>
            <given-names>Andr&#233; Silva</given-names>
          </name>
          <role>Conception and design of the research</role>
          <role>Acquisition of data</role>
          <role>Analysis and interpretation of the data</role>
          <role>Statistical analysis</role>
          <role>Writing of the manuscript</role>
          <xref ref-type="aff" rid="aff6">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="c2"/>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-0489-3737</contrib-id>
          <name>
            <surname>Castilho</surname>
            <given-names>F&#225;bio Morato de</given-names>
          </name>
          <role>Conception and design of the research</role>
          <role>Acquisition of data</role>
          <role>Analysis and interpretation of the data</role>
          <role>Writing of the manuscript</role>
          <role>Critical revision of the manuscript for content</role>
          <xref ref-type="aff" rid="aff7">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ribeiro</surname>
            <given-names>Aloisio Joaquim Freitas</given-names>
          </name>
          <role>Analysis and interpretation of the data</role>
          <role>Statistical analysis</role>
          <xref ref-type="aff" rid="aff8">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0001-8260-9212</contrib-id>
          <name>
            <surname>Passaglia</surname>
            <given-names>Luiz Guilherme</given-names>
          </name>
          <role>Conception and design of the research</role>
          <role>Acquisition of data</role>
          <role>Analysis and interpretation of the data</role>
          <role>Critical revision of the manuscript for content</role>
          <xref ref-type="aff" rid="aff6">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0003-0674-5997</contrib-id>
          <name>
            <surname>Taniguchi</surname>
            <given-names>Fabio Papa</given-names>
          </name>
          <role>Conception and design of the research</role>
          <role>Acquisition of data</role>
          <role>Obtaining financing</role>
          <xref ref-type="aff" rid="aff9">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-2740-0042</contrib-id>
          <name>
            <surname>Ribeiro</surname>
            <given-names>Antonio L.</given-names>
          </name>
          <role>Conception and design of the research</role>
          <role>Analysis and interpretation of the data</role>
          <role>Writing of the manuscript</role>
          <role>Critical revision of the manuscript for content</role>
          <xref ref-type="aff" rid="aff10">
            <sup>5</sup>
          </xref>
        </contrib>
        <aff id="aff6">
          <label>1</label>
          <addr-line>
            <named-content content-type="city">Belo Horizonte</named-content>
            <named-content content-type="state">MG</named-content>
          </addr-line>
          <country country="BR">Brazil</country>
          <institution content-type="original">Universidade Federal de Minas Gerais - Servi&#231;o de Cardiologia HC- UFMG, Belo Horizonte, MG &#8211; Brazil</institution>
        </aff>
        <aff id="aff7">
          <label>2</label>
          <addr-line>
            <named-content content-type="city">Belo Horizonte</named-content>
            <named-content content-type="state">MG</named-content>
          </addr-line>
          <country country="BR">Brazil</country>
          <institution content-type="original">Universidade Federal de Minas Gerais - Departamento de Cl&#237;nica M&#233;dica - Faculdade de Medicina &#8211; UFMG, Belo Horizonte, MG &#8211; Brazil</institution>
        </aff>
        <aff id="aff8">
          <label>3</label>
          <addr-line>
            <named-content content-type="city">Belo Horizonte</named-content>
            <named-content content-type="state">MG</named-content>
          </addr-line>
          <country country="BR">Brazil</country>
          <institution content-type="original">Universidade Federal de Minas Gerais - Departamento de Estat&#237;stica, Belo Horizonte, MG &#8211; Brazil</institution>
        </aff>
        <aff id="aff9">
          <label>4</label>
          <addr-line>
            <named-content content-type="city">S&#227;o Paulo</named-content>
            <named-content content-type="state">SP</named-content>
          </addr-line>
          <country country="BR">Brazil</country>
          <institution content-type="original">Hospital do Cora&#231;&#227;o, S&#227;o Paulo, SP &#8211; Brazil</institution>
        </aff>
        <aff id="aff10">
          <label>5</label>
          <addr-line>
            <named-content content-type="city">Belo Horizonte</named-content>
            <named-content content-type="state">MG</named-content>
          </addr-line>
          <country country="BR">Brazil</country>
          <institution content-type="original">Universidade Federal de Minas Gerais - Centro de Telessa&#250;de - Hospital das Cl&#237;nicas &#8211; UFMG, Belo Horizonte, MG &#8211; Brazil</institution>
        </aff>
      </contrib-group>
      <author-notes>
        <corresp id="c2"><bold>Mailing Address: Andr&#233; Silva Rodrigues</bold> &#8226; Universidade Federal de Minas Gerais - Servi&#231;o de Cardiologia HC- UFMG - Hospital das Cl&#237;nicas - UFMG - Avenida Alfreno Balena, 110. Postal Code <postal-code>30130-100</postal-code>, Bairro Santa Efig&#234;nia, Belo Horizonte, MG - Brazil E-mail: <email>andresilva90@gmail.com</email> </corresp>
        <fn fn-type="edited-by">
          <p>Editor responsible for the review: Gl&#225;ucia Maria Moraes de Oliveira</p>
        </fn>
        <fn fn-type="conflict">
          <p>
            <bold>Potential conflict of interest</bold>
          </p>
          <p>No potential conflict of interest relevant to this article was reported.</p>
        </fn>
      </author-notes>
      <abstract>
        <title>Abstract</title>
        <sec>
          <title>Background:</title>
          <p>Heart failure (HF) contributes to a high burden of hospitalization, and its form of presentation is associated with disease prognosis.</p>
        </sec>
        <sec>
          <title>Objectives:</title>
          <p>To describe the association of hemodynamic profile of acute HF patients at hospital admission, based on congestion (wet/dry) and perfusion (cold/warm), with mortality, hospital length of stay and risk of readmission.</p>
        </sec>
        <sec>
          <title>Methods:</title>
          <p>Cohort study, with patients participating in the "Best Practice in Cardiology" program, admitted for acute HF in Brazilian public hospitals between March 2016 and December 2019, with a six-month follow-up. Characteristics of the population and hemodynamic profile at admission were analyzed, in addition to survival analysis using Cox proportional hazard model for associations between hemodynamic profile at admission and mortality, and logistic regression for the risk of rehospitalization, using a statistical significance level of 5%.</p>
        </sec>
        <sec>
          <title>Results:</title>
          <p>A total of 1,978 patients were assessed, with mean age of 60.2 (&#177;14.8) years and mean left ventricular ejection fraction of 39.8% (&#177;17.3%). A high six-month mortality rate (22%) was observed, with an association of cold hemodynamic profiles with in-hospital mortality (HR=1.72, 95%CI 1.27-2.31; p &lt; 0.001) and six-month mortality (HR= 1.61, 95%CI 1.29-2.02). Six-month rehospitalization rate was 22%, and higher among patients with wet profiles (OR 2.30; 95%CI 1.45-3.65; p &lt; 0.001).</p>
        </sec>
        <sec>
          <title>Conclusions:</title>
          <p>Acute HF is associated with high mortality and rehospitalization rates. Patient hemodynamic profile at admission is a good prognostic marker of this condition.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords:</title>
        <kwd>Heart Failure</kwd>
        <kwd>Mortality</kwd>
        <kwd>Hospitalization</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <sec sec-type="intro">
        <title>Introduction</title>
        <p>Heart failure (HF) is a complex syndrome that causes high admission and mortality rates. Among cardiovascular diseases, HF is the main cause of hospitalization in Brazil, accounting for more than three million admissions over the last 10 years.<sup><xref ref-type="bibr" rid="B1">1</xref></sup> In-hospital mortality among patients admitted for acute HF is still high &#8211; 12.6% in 2015 BREATHE registry.<sup><xref ref-type="bibr" rid="B2">2</xref></sup></p>
        <p>International registries, however, present lower mortality rates, 5.5% during hospitalization and 26.7% one-year post-discharge in Europe.<sup><xref ref-type="bibr" rid="B3">3</xref></sup> In the large ADHERE registry,<sup><xref ref-type="bibr" rid="B4">4</xref></sup> mean hospital mortality rate for acute HF was 3.5%. These rates vary according to clinical profiles based on congestion and perfusion at admission, with an increase of up to 66% in the likelihood of death in patients with a cold-wet profile as compared with those with a warm-dry profile.<sup><xref ref-type="bibr" rid="B5">5</xref></sup></p>
        <p>Clinical assessment of perfusion (blood pressure, pulse pressure, peripheral perfusion, altered consciousness) and congestion (increased jugular venous pressure, orthopnea, edema, B3) determines patient hemodynamic profile: warm-dry, warm-wet, cold-dry and cold-wet, which is associated with disease severity and prognosis.<sup><xref ref-type="bibr" rid="B6">6</xref></sup> This classification was first described by Diamond-Forrester<sup><xref ref-type="bibr" rid="B7">7</xref></sup> in 1976, for patients who had suffered acute myocardial infarction. In the context of HF, Stevenson LW<sup><xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref></sup> published several studies on the importance of recognizing clinical signs of congestion and hypoperfusion in patients admitted with acute HF to receive therapy guided by the hemodynamic profile, prioritizing diuretic therapy and vasodilation in patients with wet profile and inotropic therapy for patients with cold profiles.<sup><xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref></sup></p>
        <p>It is expected that the hemodynamic profile at admission will be a good prognostic marker of acute HF in Brazil and help to characterize the current behavior of the disease in the country. By associating the hemodynamic profile at admission with the outcomes mortality and risk of rehospitalization, specific interventions to each profile may be used to achieve better results.</p>
      </sec>
      <sec>
        <title>Objectives</title>
        <p>The aim of the present study was to demonstrate the association between patient hemodynamic profile at hospital admission and major cardiovascular outcomes &#8211; overall in-hospital mortality (primary outcome) and six-month mortality (in-hospital and during follow-up); hospital length of stay and six-month readmission rate (secondary outcomes).</p>
      </sec>
      <sec sec-type="methods">
        <title>Methods</title>
        <p>This was cohort study, with patients admitted for acute HF in 17 public hospitals in Brazil from March 2016 to December 2019. These institutions are tertiary hospitals located in the five Brazilian geographic regions, participants of the Brazilian Society of Cardiology guideline for Best Practice in Cardiology (BPC). The BPC is inspired in the American Heart Association's Get With The Guidelines (GWTG) and aims to assess adherence rates to performance indicators recommended by the Brazilian and the American guidelines. The BPC design and results were described in previous publications.<sup><xref ref-type="bibr" rid="B10">10</xref>-<xref ref-type="bibr" rid="B12">12</xref></sup></p>
        <sec>
          <title>Population</title>
          <p>Patients aged 18 years or older, admitted with acute HF (IDC 10 I50; I50.0; I50.1 or I50.9) in the participating hospitals were included. Patients who would be transferred to other institutions, those with an expected length of stay less than 24 hours, and HF patients with other possible causes of dyspnea were excluded.</p>
        </sec>
        <sec>
          <title>Data collection</title>
          <p>Data were collected prospectively during hospitalization, using electronic medical records and specific forms, and by telephone interview administered by trained interviewers at 30 days and six months after discharge. All participants signed an informed consent form, and the study was approved by the ethics committee of the coordinating center &#8211; HCor Sao Paulo &#8211; (approval number 48561715.5.1001.0060) and the ethics committee of UFMG General Hospital (approval number 1.487.029).</p>
        </sec>
        <sec>
          <title>Hemodynamic profiles</title>
          <p>Patient hemodynamic profile was clinically determined by the doctor in charge of patient admission. The profiles were defined as: dry-warm (no signs of decompensation); warm-wet (well perfused but congested); warm-wet (well perfused, but congested); cold-dry (poor peripheral perfusion, but no congestion); cold-wet (poor perfusion and congested). In this classification into four categories, there are two levels of exposure: perfusion (cold or warm) and congestion (wet or dry). Based on this, survival analysis and multivariate analysis were performed to estimate the risks for the outcomes of interest for the four classical profiles, as well as for the perfusion (cold profiles x warm profiles) and congestion (wet profiles x dry profiles) patterns.</p>
        </sec>
        <sec>
          <title>Statistical analysis</title>
          <p>In the descriptive analysis of the outcome variables and the covariable of interest by hemodynamic profiles, continuous variables were described as mean &#177; standard deviation or median and interquartile range (Q1 and Q3) according to data normality (Shapiro Wilk test). Categorical variables were described as absolute and relative frequencies. The hemodynamic profiles were compared by the chi-square test (categorical variables) and by the Kruskal-Wallis test (quantitative variables). Multiple comparisons were made by the Dunn test (quantitative variables) and the Z test for two proportions (categorical variables), using the Holm correction method. These analyses were made using the rstatix package of the R software.</p>
          <p>Survival curves were constructed using the Kaplan-Meier method, by univariate analysis, to evaluate the effect of the hemodynamic profile (in four and two categories) at admission on mortality during the study follow-up period &#8211; six months (log-rank test). The reference group for calculation of risks and chances was the warm-dry group.</p>
          <p>The Cox proportional hazards model was used to investigate the influence of the hemodynamic profiles on mortality during hospitalization and on six-month follow-up, controlling the effects of age, sex, presence of comorbidities at admission and left ventricular ejection fraction (LVEF), in an incremental way. To assess the influence of the hemodynamic profiles on the occurrence of at least one readmission in six months, regression logistic models were used, with the same control variables included in the Cox model, in addition to the follow-up period after discharge.</p>
          <p>The significance level was set at 5%. All analyses were performed using the stats, rstatix, survival, survminer, and mice packages of the R software (R Core Team, 2020).</p>
        </sec>
        <sec>
          <title>Treatment of missing data</title>
          <p>The hemodynamic profile of 784 (28%) patients was not informed, who were then excluded from the study. Comparison of the groups with and without information on the hemodynamic profile regarding the primary outcome (death during hospitalization) did not reveal a significant difference between them (p=0.08; <xref ref-type="app" rid="app2">Supplementary Table 1</xref>), corroborating the assumption of random data loss.</p>
          <p>Among the patients with valid information about the hemodynamic profile, LVEF values of 96 were missing. These missing variables were imputed using the multiple imputation method (pmm, predictive mean matching), available in the MICE (Multivariate Imputation by Chained Equation) package of the R software,<sup><xref ref-type="bibr" rid="B13">13</xref></sup> resulting in 10 complete sets. In this imputation model, the variables sex, age, presence of comorbidities, hemodynamic profile and estimate of the risk of death during hospitalization (Nelson Aalen method) were used. In addition, data on medication of 679 patients were missing. Since this information was used in the sample description only, these values were not imputed.</p>
          <p>For the secondary outcome (readmission within six months), 1,543 patients were assessed, consisting of 215 participants where two telephone contacts were unsuccessful during this period subtracted from 1,758 survivors (12% of loss to follow-up).</p>
        </sec>
      </sec>
      <sec sec-type="results">
        <title>Results</title>
        <sec>
          <title>Description of the sample at admission</title>
          <p>Of the 2,762 patients included in the cohort until 2019, the analysis included data from 1,978 patients with data on hemodynamic profile available on their medical records. Baseline data are described in <xref ref-type="table" rid="t4">Table 1</xref>, stratified by the hemodynamic profile at admission. Mean age of the study population was 60 years; most patients were male, with low educational attainment (65% illiterate or elementary school) and low income (73.2% receiving up to two minimum wages of family income). The most common comorbidities reported by the patients at admission were hypertension, diabetes mellitus and atrial fibrillation.</p>
          <table-wrap id="t4">
            <label>Table 1</label>
            <caption>
              <title>Baseline characteristics of patients, stratified by hemodynamic profile</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup width="16%">
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
              </colgroup>
              <thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
                <tr style="background-color:#78B2CB;">
                  <th align="left" valign="middle">Baseline characteristics</th>
                  <th align="center" valign="middle">Total (N=1978)</th>
                  <th align="center" valign="middle">Warm-dry (n=183)</th>
                  <th align="center" valign="middle">Warm-wet (n=1435)</th>
                  <th align="center" valign="middle">Cold-wet (n=298)</th>
                  <th align="center" valign="middle">Cold-dry (n=62)</th>
                </tr>
              </thead>
              <tbody style="border-bottom: thin solid; border-color: #000000">
                <tr>
                  <td align="left" valign="top">G&#234;nero masculino<xref ref-type="table-fn" rid="TFN7">*</xref> - n (%)</td>
                  <td align="center" valign="top">1154 (58.3)</td>
                  <td align="center" valign="top">91 (49.7)</td>
                  <td align="center" valign="top">832 (58)</td>
                  <td align="center" valign="top">191 (64.1)</td>
                  <td align="center" valign="top">40 (64.5)</td>
                </tr>
                <tr style="background-color:#C5DDEA;">
                  <td align="left" valign="top">Mean age (SD)</td>
                  <td align="center" valign="top">60.2 (14.8)</td>
                  <td align="center" valign="top">54.8 (16.7)</td>
                  <td align="center" valign="top">61.1 (14.4)</td>
                  <td align="center" valign="top">59.2 (14.9)</td>
                  <td align="center" valign="top">61.8 (14.4)</td>
                </tr>
                <tr>
                  <td align="left" valign="top">
                    <bold>Educational attainment</bold>
                    <xref ref-type="table-fn" rid="TFN7">*</xref>
                    <bold>- n (%)</bold>
                  </td>
                  <td align="center" valign="top"/>
                  <td align="center" valign="top"/>
                  <td align="center" valign="top"/>
                  <td align="center" valign="top"/>
                  <td align="center" valign="top"/>
                </tr>
                <tr>
                  <td align="left" valign="top">Illiterate</td>
                  <td align="center" valign="top">192 (9.7)</td>
                  <td align="center" valign="top">16 (8.7)</td>
                  <td align="center" valign="top">152 (10.6)</td>
                  <td align="center" valign="top">21 (7)</td>
                  <td align="center" valign="top">3 (4.8)</td>
                </tr>
                <tr>
                  <td align="left" valign="top">Elementary school</td>
                  <td align="center" valign="top">1094 (55.3)</td>
                  <td align="center" valign="top">85 (46.4)</td>
                  <td align="center" valign="top">817 (56.9)</td>
                  <td align="center" valign="top">157 (52.7)</td>
                  <td align="center" valign="top">35 (56.5)</td>
                </tr>
                <tr>
                  <td align="left" valign="top">High school</td>
                  <td align="center" valign="top">519 (26.2)</td>
                  <td align="center" valign="top">65 (35.5)</td>
                  <td align="center" valign="top">353 (24.6)</td>
                  <td align="center" valign="top">81 (27.2)</td>
                  <td align="center" valign="top">20 (32.3)</td>
                </tr>
                <tr>
                  <td align="left" valign="top">Higher education</td>
                  <td align="center" valign="top">169 (8.5)</td>
                  <td align="center" valign="top">17 (9.3)</td>
                  <td align="center" valign="top">112 (7.8)</td>
                  <td align="center" valign="top">36 (12.1)</td>
                  <td align="center" valign="top">4 (6.5)</td>
                </tr>
                <tr style="background-color:#C5DDEA;">
                  <td align="left" valign="top">
                    <bold>Family income</bold>
                    <xref ref-type="table-fn" rid="TFN7">*</xref>
                    <bold>- n (%)</bold>
                  </td>
                  <td align="center" valign="top"/>
                  <td align="center" valign="top"/>
                  <td align="center" valign="top"/>
                  <td align="center" valign="top"/>
                  <td align="center" valign="top"/>
                </tr>
                <tr style="background-color:#C5DDEA;">
                  <td align="left" valign="top">&lt;1 minimum wage (U$ 270)</td>
                  <td align="center" valign="top">656 (33.2)</td>
                  <td align="center" valign="top">82 (44.8)</td>
                  <td align="center" valign="top">467 (32.5)</td>
                  <td align="center" valign="top">93 (31.2)</td>
                  <td align="center" valign="top">14 (22.6)</td>
                </tr>
                <tr style="background-color:#C5DDEA;">
                  <td align="left" valign="top">1 - 2 wages (U$ 270- 540)</td>
                  <td align="center" valign="top">792 (40)</td>
                  <td align="center" valign="top">53 (29)</td>
                  <td align="center" valign="top">608 (42.4)</td>
                  <td align="center" valign="top">108 (36.2)</td>
                  <td align="center" valign="top">23 (37.1)</td>
                </tr>
                <tr style="background-color:#C5DDEA;">
                  <td align="left" valign="top">2 - 5 wages (U$ 540- 1350)</td>
                  <td align="center" valign="top">433 (21.9)</td>
                  <td align="center" valign="top">39 (21.3)</td>
                  <td align="center" valign="top">301 (21)</td>
                  <td align="center" valign="top">71 (23.8)</td>
                  <td align="center" valign="top">22 (35.5)</td>
                </tr>
                <tr style="background-color:#C5DDEA;">
                  <td align="left" valign="top">&gt; 5 wages (&gt; U$ 540)</td>
                  <td align="center" valign="top">90 (4.6)</td>
                  <td align="center" valign="top">8 (4.4)</td>
                  <td align="center" valign="top">57 (4)</td>
                  <td align="center" valign="top">22 (7.4)</td>
                  <td align="center" valign="top">3 (4.8)</td>
                </tr>
                <tr>
                  <td align="left" valign="top">
                    <bold>Self-reported comorbidities, n (%)</bold>
                  </td>
                  <td align="center" valign="top"/>
                  <td align="center" valign="top"/>
                  <td align="center" valign="top"/>
                  <td align="center" valign="top"/>
                  <td align="center" valign="top"/>
                </tr>
                <tr>
                  <td align="left" valign="top">Arterial hypertension<xref ref-type="table-fn" rid="TFN7">*</xref> </td>
                  <td align="center" valign="top">1351(68.3)</td>
                  <td align="center" valign="top">111 (60.7)</td>
                  <td align="center" valign="top">1028 (71.6)</td>
                  <td align="center" valign="top">178 (59.7)</td>
                  <td align="center" valign="top">34 (54.8)</td>
                </tr>
                <tr>
                  <td align="left" valign="top">Diabetes mellitus</td>
                  <td align="center" valign="top">652 (33)</td>
                  <td align="center" valign="top">48 (26.2)</td>
                  <td align="center" valign="top">497 (34.6)</td>
                  <td align="center" valign="top">92 (30.9)</td>
                  <td align="center" valign="top">15 (24.2)</td>
                </tr>
                <tr>
                  <td align="left" valign="top">Chagas disease<xref ref-type="table-fn" rid="TFN7">*</xref> </td>
                  <td align="center" valign="top">208 (10.5)</td>
                  <td align="center" valign="top">12 (6.6)</td>
                  <td align="center" valign="top">135 (9.4)</td>
                  <td align="center" valign="top">51 (17.1)</td>
                  <td align="center" valign="top">10 (16.1)</td>
                </tr>
                <tr>
                  <td align="left" valign="top">Coronary artery disease</td>
                  <td align="center" valign="top">285 (14.4)</td>
                  <td align="center" valign="top">20 (10.9)</td>
                  <td align="center" valign="top">217 (15.1)</td>
                  <td align="center" valign="top">42 (14.1)</td>
                  <td align="center" valign="top">6 (9.7)</td>
                </tr>
                <tr>
                  <td align="left" valign="top">Atrial fibrillation/ flutter<xref ref-type="table-fn" rid="TFN7">*</xref> </td>
                  <td align="center" valign="top">503 (25.4)</td>
                  <td align="center" valign="top">30 (16.4)</td>
                  <td align="center" valign="top">375 (26.1)</td>
                  <td align="center" valign="top">75 (25.2)</td>
                  <td align="center" valign="top">23 (37.1)</td>
                </tr>
                <tr>
                  <td align="left" valign="top">Chronic kidney disease<xref ref-type="table-fn" rid="TFN7">*</xref> </td>
                  <td align="center" valign="top">309 (15.6)</td>
                  <td align="center" valign="top">8 (4.4)</td>
                  <td align="center" valign="top">227 (15.8)</td>
                  <td align="center" valign="top">60 (20.1)</td>
                  <td align="center" valign="top">14 (22.6)</td>
                </tr>
                <tr style="background-color:#C5DDEA;">
                  <td align="left" valign="top">
                    <bold>Functional class</bold>
                    <xref ref-type="table-fn" rid="TFN7">*</xref>
                    <bold>n (%)</bold>
                  </td>
                  <td align="center" valign="top"/>
                  <td align="center" valign="top"/>
                  <td align="center" valign="top"/>
                  <td align="center" valign="top"/>
                  <td align="center" valign="top"/>
                </tr>
                <tr style="background-color:#C5DDEA;">
                  <td align="left" valign="top">I-II</td>
                  <td align="center" valign="top">208 (10.5)</td>
                  <td align="center" valign="top">67 (36.6)</td>
                  <td align="center" valign="top">114 (7.9)</td>
                  <td align="center" valign="top">18 (6)</td>
                  <td align="center" valign="top">9 (14.5)</td>
                </tr>
                <tr style="background-color:#C5DDEA;">
                  <td align="left" valign="top">III-IV</td>
                  <td align="center" valign="top">1393 (70.4)</td>
                  <td align="center" valign="top">102 (55.7)</td>
                  <td align="center" valign="top">1032 (71.9)</td>
                  <td align="center" valign="top">212 (71.1)</td>
                  <td align="center" valign="top">47 (75.8)</td>
                </tr>
                <tr style="background-color:#C5DDEA;">
                  <td align="left" valign="top">Not informed</td>
                  <td align="center" valign="top">377 (19.1)</td>
                  <td align="center" valign="top">14 (7.7)</td>
                  <td align="center" valign="top">289 (20.1)</td>
                  <td align="center" valign="top">68 (22.8)</td>
                  <td align="center" valign="top">6 (9.7)</td>
                </tr>
                <tr style="background-color:#C5DDEA;">
                  <td align="left" valign="top">
                    <bold>Ejection fraction</bold>
                    <xref ref-type="table-fn" rid="TFN7">*</xref>
                    <bold>n (%)</bold>
                  </td>
                  <td align="center" valign="top"/>
                  <td align="center" valign="top"/>
                  <td align="center" valign="top"/>
                  <td align="center" valign="top"/>
                  <td align="center" valign="top"/>
                </tr>
                <tr style="background-color:#C5DDEA;">
                  <td align="left" valign="top">&gt; 50%</td>
                  <td align="center" valign="top">509 (25.7)</td>
                  <td align="center" valign="top">77 (42.1)</td>
                  <td align="center" valign="top">383 (26.7)</td>
                  <td align="center" valign="top">37 (12.4)</td>
                  <td align="center" valign="top">12 (19.4)</td>
                </tr>
                <tr style="background-color:#C5DDEA;">
                  <td align="left" valign="top">41-50%</td>
                  <td align="center" valign="top">232 (11.7)</td>
                  <td align="center" valign="top">24 (13.1)</td>
                  <td align="center" valign="top">173 (12.1)</td>
                  <td align="center" valign="top">23 (7.7)</td>
                  <td align="center" valign="top">12 (19.4)</td>
                </tr>
                <tr style="background-color:#C5DDEA;">
                  <td align="left" valign="top">&#8804; 40%</td>
                  <td align="center" valign="top">1135 (57.4)</td>
                  <td align="center" valign="top">66 (36.1)</td>
                  <td align="center" valign="top">808 (56.3)</td>
                  <td align="center" valign="top">224 (59.7)</td>
                  <td align="center" valign="top">37 (59.7)</td>
                </tr>
                <tr style="background-color:#C5DDEA;">
                  <td align="left" valign="top">Previous heart failure &#8211; n (%)</td>
                  <td align="center" valign="top">1578 (79.8)</td>
                  <td align="center" valign="top">147 (80.3)</td>
                  <td align="center" valign="top">1131 (78.9)</td>
                  <td align="center" valign="top">243 (81.5)</td>
                  <td align="center" valign="top">57 (79.8)</td>
                </tr>
                <tr style="background-color:#C5DDEA;">
                  <td align="left" valign="top">Hospitalizations in the last six months<xref ref-type="table-fn" rid="TFN7">*</xref>- n (%)</td>
                  <td align="center" valign="top">651 (32.9)</td>
                  <td align="center" valign="top">65 (35.5)</td>
                  <td align="center" valign="top">444 (30.9)</td>
                  <td align="center" valign="top">124 (41.7)</td>
                  <td align="center" valign="top">18 (29.1)</td>
                </tr>
                <tr>
                  <td align="left" valign="top">
                    <bold>Previous Medications - n (%)</bold>
                    <xref ref-type="table-fn" rid="TFN8">&#8224;</xref>
                  </td>
                  <td align="center" valign="top"/>
                  <td align="center" valign="top"/>
                  <td align="center" valign="top"/>
                  <td align="center" valign="top"/>
                  <td align="center" valign="top"/>
                </tr>
                <tr>
                  <td align="left" valign="top">Betablockers<xref ref-type="table-fn" rid="TFN7">*</xref> </td>
                  <td align="center" valign="top">926 (71.3)</td>
                  <td align="center" valign="top">75 (61)</td>
                  <td align="center" valign="top">676 (71)</td>
                  <td align="center" valign="top">147 (77)</td>
                  <td align="center" valign="top">28 (84.8)</td>
                </tr>
                <tr>
                  <td align="left" valign="top">ACEI or ARB</td>
                  <td align="center" valign="top">854 (65.7)</td>
                  <td align="center" valign="top">80 (65)</td>
                  <td align="center" valign="top">616 (64.7)</td>
                  <td align="center" valign="top">137 (71.7)</td>
                  <td align="center" valign="top">21 (63.6)</td>
                </tr>
                <tr>
                  <td align="left" valign="top">Spironolactone<xref ref-type="table-fn" rid="TFN7">*</xref> </td>
                  <td align="center" valign="top">524 (40.3)</td>
                  <td align="center" valign="top">45 (36.6)</td>
                  <td align="center" valign="top">348 (36.6)</td>
                  <td align="center" valign="top">109 (57.1)</td>
                  <td align="center" valign="top">22 (66.7)</td>
                </tr>
                <tr>
                  <td align="left" valign="top">Loop diuretics<xref ref-type="table-fn" rid="TFN7">*</xref> </td>
                  <td align="center" valign="top">885 (68.1)</td>
                  <td align="center" valign="top">72 (58.5)</td>
                  <td align="center" valign="top">648 (68.1)</td>
                  <td align="center" valign="top">137 (71.7)</td>
                  <td align="center" valign="top">28 (84.8)</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN7">
                <label>*</label>
                <p>p value &lt; 0.05 for differences between the hemodynamic profiles (chi-square test);</p>
              </fn>
              <fn id="TFN8">
                <label>&#8224;</label>
                <p>N= 1,299 for missing data about the use of previous medications; ACEI: angiotensin converting enzyme inhibitors; ARB: angiotensin receptor blocker.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>Most patients already had a previous HF diagnosis (decompensated HF) and had a New York Association (NYHA) functional class III-IV. The most frequent etiologies of HF during hospitalization (defined after tests, by an assistant staff) were idiopathic (23.3%), ischemic (21.3%), hypertensive (16.1%), valvar (15.3%) and Chagas cardiomyopathy (9.9%), among others (14.1%) (<xref ref-type="app" rid="app2">Supplementary Table 2</xref>). Most patients had HF with reduced LVEF (&#8804; 40%), with a mean of 39.8% (&#177;17,3%), and the most frequent hemodynamic profile at admission was the warm-wet profile.</p>
        </sec>
        <sec>
          <title>Analysis of the outcomes of interest</title>
          <p>A total of 220 in-hospital deaths occurred, corresponding to an overall mortality of 11.1%. In-hospital mortality rate was higher in patients admitted for poor peripheral perfusion (cold profile) &#8211; 21.5% for the cold-wet profile and 14.5% for the cold-dry profile. Only 10 patients (0.5% of the sample) underwent heart transplantation during hospitalization. During the study period (hospitalization and six-month follow-up), overall mortality rate was 22%, 32% in patients with a cold-wet profile. In addition, hospital length of stay varied significantly across the hemodynamic profiles, with a median of 17 (9-33) in the general population and 23 (13-42) days in the cold-wet profile (<xref ref-type="table" rid="t5">Table 2</xref>).</p>
          <table-wrap id="t5">
            <label>Table 2</label>
            <caption>
              <title>Primary and secondary outcomes by hemodynamic profile</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup width="14%">
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
              </colgroup>
              <thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
                <tr style="background-color:#78B2CB;">
                  <th align="left" valign="middle">Outcomes</th>
                  <th align="center" valign="middle">Total (N=1978)</th>
                  <th align="center" valign="middle">Warm-dry Group 1 (n=183)</th>
                  <th align="center" valign="middle">Warm-wet Group 2 (n=1435)</th>
                  <th align="center" valign="middle">Cold-wet Group 3 (n=298)</th>
                  <th align="center" valign="middle">Cold-dry Group 4 (n=62)</th>
                  <th align="center" valign="middle">p-value</th>
                </tr>
              </thead>
              <tbody style="border-bottom: thin solid; border-color: #000000">
                <tr>
                  <td align="left" valign="top">In-hospital deaths N (%)</td>
                  <td align="center" valign="top">220 (11.1)</td>
                  <td align="center" valign="top">14 (7.7)</td>
                  <td align="center" valign="top">133 (9.3)</td>
                  <td align="center" valign="top">64 (21.5)</td>
                  <td align="center" valign="top">9 (14.5)</td>
                  <td align="center" valign="top">&lt;0.001 (1=2&#8800;3=4)</td>
                </tr>
                <tr style="background-color:#C5DDEA;">
                  <td align="left" valign="top">Overall mortality (hospitalization + 6- month follow-up)- N (%)</td>
                  <td align="center" valign="top">432 (22)</td>
                  <td align="center" valign="top">32 (16)</td>
                  <td align="center" valign="top">290 (20)</td>
                  <td align="center" valign="top">96 (32)</td>
                  <td align="center" valign="top">14 (22)</td>
                  <td align="center" valign="top">&lt;0.001 (1=2&#8800;3=4)</td>
                </tr>
                <tr>
                  <td align="left" valign="top">Days of hospitalization Median (interquartile range)</td>
                  <td align="center" valign="top">17 (9-33)</td>
                  <td align="center" valign="top">22 (10-35)</td>
                  <td align="center" valign="top">16 (8-30)</td>
                  <td align="center" valign="top">23 (13-42)</td>
                  <td align="center" valign="top">15 (10-32)</td>
                  <td align="center" valign="top">&lt;0.001 (1&#8800;2=3=4)</td>
                </tr>
                <tr style="background-color:#C5DDEA;">
                  <td align="left" valign="top">Rehospitalization<xref ref-type="table-fn" rid="TFN9">*</xref>- N(%)</td>
                  <td align="center" valign="top">334 (22)</td>
                  <td align="center" valign="top">18 (11.5)</td>
                  <td align="center" valign="top">262 (23)</td>
                  <td align="center" valign="top">48 (23.8)</td>
                  <td align="center" valign="top">6 (13)</td>
                  <td align="center" valign="top">0.004 (1&#8800;2=3&#8800;4)</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN9">
                <label>*</label>
                <p>N=1543 due to loss to follow-up (deaths during hospitalization and follow-up losses).</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>In the six-month period after hospital discharge, 1,543 patients were contacted twice by telephone. Of these patients, 334 (22%) patients were readmitted at least once, and a significant effect of the hemodynamic profile at admission was observed on this outcome. In this regard, rehospitalization was more frequent in congested patients (wet profiles), 23% in the warm-wet group, and 23.8% in the cold-wet group, and only in 11.5% and 10.9% in the warm-dry and cold-dry profiles, respectively (<xref ref-type="table" rid="t5">Table 2</xref>).</p>
          <p>In the univariate survival data analysis using Kaplan-Meier curves, an association between clinical profile at admission and mortality in the whole study period (hospitalization + six-month follow-up) was observed, with a higher mortality among patients with the cold-wet profile as compared with the others (p &lt; 0.0001, log-rank test). Analysis of congestion and perfusion alone revealed that cold profiles were associated with higher mortality in the follow-up than warm profiles (p &lt; 0.0001, log-rank test), which was not observed in wet <italic>versus</italic> dry profiles (p = 0.08, log-rank test) (<xref ref-type="fig" rid="f2">Central Illustration</xref>).</p>
          <fig id="f2">
            <caption>
              <title>Kaplan-Meier (KM) curves for overall mortality.</title>
            </caption>
            <graphic xlink:href="1678-4170-abc-121-05-e20230699-30699-gf01-en.tif"/></fig>
        </sec>
        <sec>
          <title>Multivariate analysis</title>
          <p>Patients admitted with a cold-wet profile and patients with a cold-dry profile showed an increased risk of in-hospital death as compared with those with a warm-dry profile (HR= 2.2, 95%CI 1.20-4.04 and 2.39, 95%CI 1.02-5.57, respectively). On the other hand, the warm-wet profile was not associated with an increased risk of death (HR= 1.33; 95%CI 0.76-2.33). In the study follow-up period (up to six months after discharge), this increased risk of death was also observed in the cold-wet profile (HR= 1.96, 95%CI 1.3-3.0) (<xref ref-type="table" rid="t6">Table 3</xref>).</p>
          <table-wrap id="t6">
            <label>Table 3</label>
            <caption>
              <title>Relative risks of death estimated by Cox model and hazard ratios for readmissions estimated by logistic regression model, with 95% confidence interval, by hemodynamic profile (reference profile: warm-dry)</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup width="20%">
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
              </colgroup>
              <thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
                <tr style="background-color:#78B2CB;">
                  <th align="center" rowspan="2" valign="middle">Hemodynamic profile</th>
                  <th align="center" colspan="4" style="border-bottom: thin solid; border-color: #000000" valign="middle">Hazard ratio for in-hospital mortality (95%CI)</th>
                </tr>
                <tr style="background-color:#78B2CB;">
                  <th align="center" valign="middle">Unadjusted model</th>
                  <th align="center" valign="middle">Adjusted model (sex, age)</th>
                  <th align="center" valign="middle">Adjusted model (sex, age, comorbidities<xref ref-type="table-fn" rid="TFN11">&#8224;</xref>)</th>
                  <th align="center" valign="middle">Adjusted model (previous and LVEF<xref ref-type="table-fn" rid="TFN12">&#8225;</xref>)</th>
                </tr>
              </thead>
              <tbody style="border-bottom: thin solid; border-color: #000000">
                <tr>
                  <td align="left" valign="top">Warm and wet</td>
                  <td align="center" valign="top">1.35 (IC 0.78-2.35)</td>
                  <td align="center" valign="top">1.31 (0.75-2.27)</td>
                  <td align="center" valign="top">1.33 (0.76-2.31)</td>
                  <td align="center" valign="top">1.33 (0.76-2.33)</td>
                </tr>
                <tr>
                  <td align="left" valign="top">Cold and wet<xref ref-type="table-fn" rid="TFN10">*</xref> </td>
                  <td align="center" valign="top">2.21 (1.24-3.95)</td>
                  <td align="center" valign="top">2.15 (1.20-3.85)</td>
                  <td align="center" valign="top">2.18 (1.21-3.93)</td>
                  <td align="center" valign="top">2.20 (1.20 &#8211; 4.04)</td>
                </tr>
                <tr>
                  <td align="left" style="border-bottom: thin solid; border-color: #000000" valign="top">Cold and dry<xref ref-type="table-fn" rid="TFN10">*</xref> </td>
                  <td align="center" style="border-bottom: thin solid; border-color: #000000" valign="top">2.5 (1.08- 5.77)</td>
                  <td align="center" style="border-bottom: thin solid; border-color: #000000" valign="top">2.53 (1.09- 5.87)</td>
                  <td align="center" style="border-bottom: thin solid; border-color: #000000" valign="top">2.37 (1.02- 5.52)</td>
                  <td align="center" style="border-bottom: thin solid; border-color: #000000" valign="top">2.39 (1.02- 5.57)</td>
                </tr>
                <tr style="background-color:#78B2CB;">
                  <td align="left" rowspan="2" valign="middle">
                    <bold>Hemodynamic profile</bold>
                  </td>
                  <td align="center" colspan="4" style="border-bottom: thin solid; border-color: #000000" valign="middle">
                    <bold>Hazard ratio of death during the six-month follow-up period - HR (95%CI)</bold>
                  </td>
                </tr>
                <tr style="background-color:#78B2CB;">
                  <td align="center" valign="middle">
                    <bold>Unadjusted model</bold>
                  </td>
                  <td align="center" valign="middle">
                    <bold>Adjusted model (sex, age)</bold>
                  </td>
                  <td align="center" valign="middle">
                    <bold>Adjusted model (sex, age, comorbidities</bold>
                    <xref ref-type="table-fn" rid="TFN11">&#8224;</xref>
                    <bold>)</bold>
                  </td>
                  <td align="center" valign="middle">
                    <bold>Adjustedmodel (previous and LVEF</bold>
                    <xref ref-type="table-fn" rid="TFN12">&#8225;</xref>
                    <bold>)</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left" valign="top">Warm and wet</td>
                  <td align="center" valign="top">1.33 (0.93-1.92)</td>
                  <td align="center" valign="top">1.26 (0.87-1.82)</td>
                  <td align="center" valign="top">1.20 (0.83-1.74)</td>
                  <td align="center" valign="top">1.18 (0.82-1.72)</td>
                </tr>
                <tr>
                  <td align="left" valign="top">Cold and wet<xref ref-type="table-fn" rid="TFN9">*</xref> </td>
                  <td align="center" valign="top">2.34 (1.57- 3.5)</td>
                  <td align="center" valign="top">2.24 (1.5- 3.34)</td>
                  <td align="center" valign="top">2.02 (1.34- 3.03)</td>
                  <td align="center" valign="top">1.96 (1.3- 2.97)</td>
                </tr>
                <tr>
                  <td align="left" style="border-bottom: thin solid; border-color: #000000" valign="top">Cold and dry</td>
                  <td align="center" style="border-bottom: thin solid; border-color: #000000" valign="top">1.66 (0.89-3.11)</td>
                  <td align="center" style="border-bottom: thin solid; border-color: #000000" valign="top">1.54 (0.82-2.89)</td>
                  <td align="center" style="border-bottom: thin solid; border-color: #000000" valign="top">1.36 (0.73-2.57)</td>
                  <td align="center" style="border-bottom: thin solid; border-color: #000000" valign="top">1.34 (0.71-2.53)</td>
                </tr>
                <tr style="background-color:#78B2CB;">
                  <td align="left" rowspan="2" valign="middle">
                    <bold>Hemodynamic profile</bold>
                  </td>
                  <td align="center" colspan="4" style="border-bottom: thin solid; border-color: #000000" valign="middle">
                    <bold>Odds ratio of readmission in six months - OR (95%CI)</bold>
                  </td>
                </tr>
                <tr style="background-color:#78B2CB;">
                  <td align="center" valign="middle">
                    <bold>Unadjusted model</bold>
                  </td>
                  <td align="center" valign="middle">
                    <bold>Adjusted model (sex, age)</bold>
                  </td>
                  <td align="center" valign="middle">
                    <bold>Adjusted model (sex, age, comorbidities</bold>
                    <xref ref-type="table-fn" rid="TFN11">&#8224;</xref>
                    <bold>)</bold>
                  </td>
                  <td align="center" valign="middle">
                    <bold>Adjusted model (previous and LVEF</bold>
                    <xref ref-type="table-fn" rid="TFN12">&#8225;</xref>
                    <bold>)</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left" valign="top">Warm and wet<xref ref-type="table-fn" rid="TFN10">*</xref> </td>
                  <td align="center" valign="top">2.51 (1.54-4.33)</td>
                  <td align="center" valign="top">2.55 (1.56-4.42)</td>
                  <td align="center" valign="top">2.38 (1.45-4.14)</td>
                  <td align="center" valign="top">2.39 (1.41-4.05)</td>
                </tr>
                <tr>
                  <td align="left" valign="top">Cold and wet <xref ref-type="table-fn" rid="TFN10">*</xref> </td>
                  <td align="center" valign="top">2.75 (1.54-5.10)</td>
                  <td align="center" valign="top">2.81 (1.57-5.22)</td>
                  <td align="center" valign="top">2.57 (1.42-4.8)</td>
                  <td align="center" valign="top">2.59 (1.40-4.79)</td>
                </tr>
                <tr>
                  <td align="left" valign="top">Cold and dry</td>
                  <td align="center" valign="top">1.35 (0.46-3.49)</td>
                  <td align="center" valign="top">1.39 (0.47-3.61)</td>
                  <td align="center" valign="top">1.27 (0.43-3.34)</td>
                  <td align="center" valign="top">1.28 (0.47-3.51)</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN10">
                <label>*</label>
                <p>p value &lt; 0.05 for differences between the hemodynamic profiles;</p>
              </fn>
              <fn id="TFN11">
                <label>&#8224;</label>
                <p>Hypertension, chronic pulmonary obstructive disease, Chagas disease, coronary artery disease, diabetes, atrial fibrillation/atrial flutter);</p>
              </fn>
              <fn id="TFN12">
                <label>&#8225;</label>
                <p>Models adjusted by multiple imputation of missing LVEF (left ventricular ejection fraction) values.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>In addition, when compared with the warm-dry profile, patients admitted with a warm-wet profile (OR= 2.39; 95%CI 1.41-4.05) and those with a cold-wet profile (OR= 2.59; 95%CI 1.40-4.79) had a higher risk of readmission in six months (<xref ref-type="table" rid="t6">Table 3</xref>).</p>
          <p>We also evaluated perfusion (cold vs. warm) and congestion (wet vs. dry) separately by multivariate analysis. For the primary outcome, cold profiles increased the risk of in-hospital death when compared to warm profiles (HR= 1.61; 95%CI 1.29-2.02), whereas wet profiles did not increase this risk as compared with dry profiles (HR= 1.27; 95%CI 0.93-1.73).</p>
          <p>Regarding the risk of readmission in six months, we found that patients admitted with a wet profile showed an increased risk of readmission (OR= 2.30, 95%CI 1.45-3.65), as compared with those admitted with dry profiles. On the other hand, warm profiles were not significantly associated with an increased risk of rehospitalization (OR= 1.10; 95%CI 0.78-1.56).</p>
        </sec>
      </sec>
      <sec sec-type="discussion">
        <title>Discussion</title>
        <p>Results of the present study reveal prognostic markers for patients admitted for acute HF in Brazil. Main characteristics of these patients were low family income, mostly older males with multiple comorbidities, reduced ejection fraction and known and symptomatic HF. Distribution of HF etiology was similar to that described in the literature;<sup><xref ref-type="bibr" rid="B3">3</xref></sup> it is worth mentioning, however, the high prevalence of Chagas disease in our country, which accounted for almost 10% of the sample. Most patients were admitted to the emergency department with a warm and wet profile. High mortality and rehospitalization rates were found, with a significant association with hemodynamic profile at admission.</p>
        <p>Hospital length of stay was 10 days longer than that reported in international cohorts (mean of seven days).<sup><xref ref-type="bibr" rid="B3">3</xref></sup> This information is alarming, since the study was conducted in renowned public health centers in Brazil and reflect the difficulty in providing optimal treatment in a timely manner. This could also represent higher severity of these patients at admission due to limited access to diagnostic tests and appropriate treatment, considering the social context of the study population.</p>
        <p>In-hospital mortality rate of the present study was similar to that reported in the last Brazilian registry (11.1% x 12.6%).<sup><xref ref-type="bibr" rid="B2">2</xref></sup> This was also similar to mortality data available from the Latin America (11.1% x 11.7%).<sup><xref ref-type="bibr" rid="B14">14</xref></sup> We do know that data may vary between participating centers according to the profile of patients at admission. Recently published data from the UFMG general hospital, in Belo Horizonte, Brazil, showed a higher mortality rate (17.9%),<sup><xref ref-type="bibr" rid="B15">15</xref></sup> though the main cause of HF was Chagas disease (25.8%) and 18.3% of patients were referred for heart transplantation in the same hospitalization, confirming the severity of this sample.<sup><xref ref-type="bibr" rid="B16">16</xref></sup></p>
        <p>The cohort of the present study showed a higher in-hospital mortality (11.1%) when compared with European (5.5%)<sup><xref ref-type="bibr" rid="B3">3</xref></sup> and American (4.0%)<sup><xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B17">17</xref></sup> cohorts. When mortality was stratified by patients&#8217; hemodynamic profile at admission, cold profile has higher mortality, which represents hypotensive and more severe patients, with multiple organ failure due to HF. In our adjusted model, we found an increased risk of in-hospital death, with a hazard ratio of 2.20 (95%CI 1.20 &#8211; 4.04) for the cold-wet profile. In a similar European registry, this profile was associated with in-hospital death, with a hazard ratio of 3.47 (95%CI 2.31-5.22).<sup><xref ref-type="bibr" rid="B5">5</xref></sup> Therefore, management of these patients should be immediate and effective, in order to reverse the natural course of the cold-wet profile, with a high risk of death. Rapid response teams for cardiogenic shock and well-designed institutional protocols can contribute to better outcomes.<sup><xref ref-type="bibr" rid="B18">18</xref></sup></p>
        <p>In the analysis of overall mortality, in-hospital and six-month mortalities were grouped, revealing a statistically significant difference between the profiles, with a higher mortality for the cold-wet profile (32%). In addition, this profile showed a higher follow-up mortality risk, with a hazard ratio of 1.96 (95%CI 1.3- 2.97). European data corroborate these findings, showing a one-year mortality rate of 26.7% after hospital admission for acute HF, and 54% among patients admitted with cardiogenic shock.<sup><xref ref-type="bibr" rid="B3">3</xref></sup></p>
        <p>Another finding of this study was the higher chance of readmission in patients with wet profiles (OR = 2.30; 95%CI 1.45-3.65), who developed recurrent congestive symptoms in the follow-up. Patients with a "more congested" profile have been associated with higher one-year rehospitalization rates &#8211; 32.2% for the cold-wet profile, 26.9% for the warm-wet and 16.4% for the warm-dry profile (p&lt;0.001).<sup><xref ref-type="bibr" rid="B3">3</xref></sup> Unlike warm profiles, cold profiles were not associated with higher rehospitalization (OR= 1.10, 95%CI 0.78-1.56), which may be associated with the higher in-hospital mortality in these profiles.</p>
        <p>The 30-day period following discharge is characterized by vulnerability, during which the follow-up is crucial to reassess congestive symptoms and other complications to prevent rehospitalizations. Optimization strategies and treatment monitoring should be planned before discharge, targeting outpatient follow-up. These measures include a multidisciplinary approach: dietary counseling, adherence to drug therapy, cardiac rehabilitation programs, periodical medical examination for adjustment and tolerance to drug treatment, monitoring of biomarkers and congestive symptoms.<sup><xref ref-type="bibr" rid="B19">19</xref></sup> For example, the randomized multicentric study STRONG-HF<sup><xref ref-type="bibr" rid="B20">20</xref></sup> compared a more intensive strategy of outpatient follow-up after hospitalization for acute HF, consisting of up-titration of disease-modifying agents (betablockers, renin- angiotensin system blockers and mineralocorticoid receptor antagonists) to target doses within two weeks of discharge instead of usual care, and showed a reduction in readmission and six-month mortality from 23% to 15% (p=0.002).</p>
        <p>Limitations of the present study include the fact that it was a cohort, non-interventional study, and hence associations between hemodynamic profile and outcomes may be biased. Although losses due to reporting failure and losses to follow-up were high, all were considered in the statistical analysis. Information on readmission within six months was collected by telephone, in a categorical manner &#8211; present or absent &#8211; which precluded a better characterization of this outcome. In addition, classification of the hemodynamic profile was made at the emergency physician's discretion, which, despite subjective, is closer to reality. Also, the study was carried out in tertiary care hospitals that are local referral centers. Probably, if emergency and primary care centers, as well as secondary care hospitals were included, our results may have been different.</p>
      </sec>
      <sec sec-type="conclusions">
        <title>Conclusion</title>
        <p>Acute HF has high morbidity and mortality in Brazil and is related to the hemodynamic profile of patients at admission. Patients admitted with a cold profile (poorly perfused) had a 72% increased risk of in-hospital death and a 61% increased risk of death during the six-month follow-up. Congested patients (we profile) had 2.3 times greater chance of readmission in six months.</p>
      </sec>
    </body>
    <back>
      <fn-group>
        <fn fn-type="financial-disclosure">
          <p>
            <bold>Sources of funding</bold>
          </p>
          <p>There were no external funding sources for this study.</p>
        </fn>
        <fn fn-type="other" id="fn5">
          <p>
            <bold>Study association</bold>
          </p>
          <p>This article is part of the thesis of master submitted by Andr&#233; Silva Rodrigues, Universidade Federal de Minas Gerais.</p>
        </fn>
        <fn fn-type="other" id="fn6">
          <p>
            <bold>Ethics approval and consent to participate</bold>
          </p>
          <p>This study was approved by the Ethics Committee of the da Universidade Federal de Minas Gerais under the protocol number 1.487.029. All the procedures in this study were in accordance with the 1975 Helsinki Declaration, updated in 2013. Informed consent was obtained from all participants included in the study.</p>
        </fn>
      </fn-group>
      <app-group>
        <app id="app2">
          <title>*Supplemental Materials</title>
          <p>For additional information, please click <ext-link ext-link-type="uri" xlink:href="https://abccardiol.org/supplementary-material/2024/12105/2023-0699_suplementar_ingles.pdf">here</ext-link>.</p>
        </app>
      </app-group>
    </back>
  </sub-article>
</article>
